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The growing body of research examining simultaneous alcohol and marijuana 
(SAM) use suggests motivations for alcohol-only, marijuana-only, and SAM use, 
especially among college-aged people, warrant further examination to ultimately tailor 
interventions to not only specific substances but also the underlying motivations for using 
those substances. Thus, the purpose of the present study was to test the measurement 
invariance of a novel broadband motives measure, the Motivations for Using Substances 
Questionnaire (MUSQ), across alcohol-only, marijuana-only, and SAM users and further 
test motivations’ relationships to use-related problems. However, due to insufficient 
sample sizes of marijuana-only users (n = 175), the MUSQ was subjected to two-group 
invariance testing across alcohol-only (n = 461) and SAM users (n = 374).  
Confirmatory factor analysis of the MUSQ revealed an 8-factor baseline model 
that combined items developed from the MUSQ’s piloting study related to (a) reducing 
anxiety and unpleasant arousal, reducing negative affect, and increasing positive affect 
under one latent variable (Manage Emotional States; MES) and (b) using to manage 
negative social interactions with conformity motives under one latent variable (Manage 
Negative Social Interactions – Revised; MNSI-r). Configural and metric invariance were 
observed and partial invariance at the scalar level was demonstrated for the MUSQ across 
groups. SAM users tended to use more frequently for all motives except MNSI-r than 
alcohol-only users. MES motives consistently predicted use-related problems across 
groups. Thus, the MUSQ is a psychometrically appropriate assessment tool to evaluate 
meaningful differences in the reasons individuals use alcohol by itself and in combination 
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CHAPTER I – INTRODUCTION 
Findings from the most recent National Survey on Drug Use and Health suggest 
young adults aged 18 to 25 demonstrated the highest prevalence for both past month 
alcohol use (55.1 percent) and past year marijuana use (34.8 percent). Of greater concern, 
this age group represents the highest prevalence of alcohol use disorders (10.1 percent) 
and cannabis use disorders (5.9 percent) compared to those aged 12 to 17 and 26 and 
older (Substance Abuse and Mental Health Services Administration, 2019). Indeed, the 
overwhelming majority of full- and part-time college students at public 4-year institutions 
fall within this age range (McFarland et al., 2018) and make up a notable proportion of 
those individuals who may experience a plethora of negative consequences from alcohol, 
marijuana, or combined use. 
College students appear to be a somewhat unique group when it comes to 
problematic use of alcohol and marijuana. For example, compared to non-college peers, 
college students are more likely to drive under the influence of alcohol and engage in 
binge drinking. Alcohol use in college is also associated with greater likelihood of 
victimization of others, including assaulting others sexually and physically, as well 
increased risk of killing others by driving under the influence (Hingson, Zha, & 
Weitzman, 2009). Regarding past month marijuana use, of the college students who 
report negative consequences, the most frequently endorsed consequences include driving 
under the influence, saying or doing things that are embarrassing, feeling groggy or tired 




Of those who use alcohol, more young adults use both alcohol and marijuana 
simultaneously, (i.e., co-ingestion; 15.3 percent) as opposed to only using each within a 
given time period (e.g., using both within the past month, referred to in the existing 
literature as “concurrent use”; 7.7 percent; Subbaraman & Kerr, 2015). Simultaneous 
versus concurrent use and alcohol-only use uniquely predicts negative consequences from 
use, use frequency, and use quantity (Linden-Carmichael, Stamates, & Lau-Barraco, 
2019). Moreover, simultaneous use predicts a two- to three-fold greater likelihood of 
driving under the influence, social problems, and impairment in major life domains (e.g., 
health, finances, occupation, academic, and other social roles) compared to alcohol-only 
use, as well as a greater likelihood of driving under the influence compared to concurrent 
use (Subbaraman & Kerr, 2015). Simultaneous users also report greater acute synergistic 
effects (e.g., feeling more intoxicated, difficulty concentrating, and clumsiness) and 
exhibit greater odds for engaging in unprotected sex compared to marijuana- or alcohol-
only users (Lee, Cadigan, & Patrick, 2017; Metrik, Caswell, Magill, Monti, & Kahler, 
2016). In addition, college students who use moderate quantities of both alcohol and 
marijuana have reliably lower grade point averages (GPAs) than those who use alcohol 
only, minimal quantities of both alcohol and marijuana, and those who use neither. 
However, GPA differences between moderate concurrent and simultaneous use have yet 
to be observed (Meda et al., 2017). Past month combined marijuana and alcohol use 
(undifferentiated between concurrent and simultaneous use and controlled for binge 
drinking) by college students has also been associated with a higher frequency of missing 
classes, becoming nauseous or vomiting, and other actions later regretted compared to 
alcohol-only users (Shillington & Clapp, 2001).  
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The growing body of research investigating simultaneous alcohol and marijuana 
use (SAM) suggests that the motivations for alcohol-only, marijuana-only, and SAM use 
among college students warrant further examination, with the ultimate goal of tailoring 
interventions to not only specific substances but also to the underlying motivations for 
using those substances. Thus, the purpose of this study is to test the measurement 
invariance of a relatively novel broadband motives measure (i.e., Motivations for Using 
Substances Questionnaire) across student alcohol-only, marijuana-only, and SAM users 
and further test motivations’ relationships to use-related problems. In the next section, the 
existing literature on measurements of motives for alcohol use, marijuana use, and SAM 
use will be reviewed, highlighting the need to further examine these differences in a 
college sample using a greater breadth of motivations.  
Alcohol Use Motives 
Although several measures of alcohol use motives can be identified dating back to 
at least the 1960s (e.g., Definitions of Alcohol Scale; Mulford & Miller, 1960), we will 
focus on those measures still circulating in the literature. The Drinking Motives 
Questionnaire (DMQ) initially yielded a three-factor model of motives for alcohol use in 
a representative adult sample: (1) Coping, (2) Affective Enhancement, and (3) Social 
Rewards (Cooper, Russell, Skinner, & Windle, 1992) that was later replicated with 
college students (Stewart, Zeitlin, & Samoluk, 1995). A fourth factor emerged (i.e., 
Conformity) through the addition of items to the DMQ – Revised (DMQ-R) that targeted 
adolescent alcohol use (Cooper, 1994), and the four-factor model also appeared to fit the 
data better compared to alternative models within college samples (MacLean & Lecci, 
2000; Martens, Rocha, Martin, & Serrao, 2008). Finally, the Modified DMQ-R yielded a 
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five-factor model that, with the addition and modification of several items, separated 
Coping into Coping-Anxiety and Coping-Depression factors within a college sample 
(Grant, Stewart, O’Connor, Blackwell, & Conrod, 2007). Other less frequently utilized 
measures of alcohol use motives have yielded comparable motive factors to all versions 
of the DMQ (e.g., Carpenter & Hasin, 1998; Cronin, 1997).  
Marijuana Use Motives 
Heavily influenced by the DMQ-R, the Marijuana Motives Measure (MMM) was 
developed to index motivations to use marijuana. The MMM was created by exchanging 
the DMQ-R’s “drink” with “use marijuana” and included several items for a fifth 
Expansion (of the mind) scale. Ultimately, the inclusion of an Expansion motive scale for 
college student marijuana users predicted unique variance in frequency of use that was 
not present in alcohol users’ responses to this scale (Simons, Correia, Carey, & Borsari, 
1998). In addition, college students used marijuana for Expansion motives at a greater 
frequency than alcohol users and alcohol was used more often for Social Reasons, while 
the frequency at which alcohol and marijuana use occurred for Coping, Conformity, and 
Enhancement reasons were similar (Simons, Correia, & Carey, 2000). Thus, there 
appears to be commonality between alcohol motives and marijuana motives themselves 
(i.e., Coping, Conformity, Social Reasons, Enhancement) and the frequency at which use 
of these substances occur for Coping, Conformity, and Enhancement reasons, while the 
Expansion motives differentiate marijuana use, indicating a unique target for 
intervention. 
The Comprehensive Marijuana Motives Questionnaire (CMMQ) was developed 
initially with a qualitative approach to identify common themes for marijuana motives 
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among college students (Lee, Neighbors, & Woods, 2007; Lee, Neighbors, Hendershot, 
& Grossbard, 2009). In the pilot study, incoming college freshman self-identified their 
top five reasons for using marijuana and researchers coded the motives into 19 distinct 
motive constructs: (1) Enjoyment/Fun, (2) Conformity, (3) Experimentation, (4) Social 
Enhancement, (5) Boredom, (6) Relaxation, (7) Coping, (8) Availability, (9) Relative 
Low Risk, (10) Altered Perception or Perspectives, (11) Activity Enhancement, (12) 
Rebellion, (13) Alcohol Intoxication, (14) Food Enhancement, (15) Anxiety Reduction, 
(16) Image Enhancement, (17) Celebration, (18) Medical Use, and (19) Habit (Lee, 
Neighbors, & Woods, 2007). Through a factor analysis, the CMMQ ultimately yielded 
twelve factors: (1) Enjoyment, (2) Conformity, (3) Coping, (4) Experimentation, (5) 
Boredom, (6) Alcohol, (7) Celebration, (8) Altered Perceptions, (9) Social anxiety, (10) 
Relative Low risk,  (11) Sleep/Rest, and (12) Availability. Extending the breadth of 
motives with the CMMQ, we can see parallel motives to the MMQ (i.e., Enjoyment with 
Enhancement, Conformity with Conformity, Coping and Social Anxiety with Coping, 
Celebration with Social Reasons, Altered Perceptions and Experimentation with 
Expansion) as well as other relevant reasons for marijuana use introduced into a motive 
measure that uniquely predicted greater frequency of use (i.e., Altered Perceptions, 
Relative Low Risk, Sleep/Rest, Enjoyment, Boredom) and use-related problems (i.e., 
Coping, Sleep/Rest; Lee, Neighbors, Hendershot, & Grossbard, 2009).  
Although an Alcohol scale emerged in the CMMQ, the item content was more 
related to reduced inhibitions from alcohol leading to marijuana use (e.g., “because you 
were drunk”) as opposed to motives associated with enhancing or otherwise managing 
the effects of these or other substances. Relative Low Risk and Availability factors were 
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also novel to the measurement of marijuana motives, wherein Relative Low Risk was 
positively related to frequency of use and Availability, although not a significant 
predictor of frequency of use or use-related consequences, emerged as a salient factor, 
suggesting it may nevertheless be an important construct in understanding where to target 
interventions. Finally, although Rebellion did not emerge in the final factor structure, we 
see that it did emerge in a broadband measure of substance use motives that will be 
described later (i.e., Altenberger, 2020).  
SAM Use Motives 
In a pioneering study of SAM use motives, Patrick, Fairlie, and Lee (2018) 
developed a questionnaire that yielded four factors: (1) Conformity, (2) Positive Effects, 
(3) Calm/Coping, and (4) Social. The Conformity factor mirrored content from the 
previously mentioned Conformity content, Social included content from both Social 
Reasons and Celebration, and Calm/Coping parallel content from Social Anxiety and 
Sleep/Rest. Participants in this study completed the DMQ-R, CMMQ, and the new SAM 
motive measure. Results from these responses suggested participants most frequently 
used alcohol-only for Enhancement and Social Reasons motives, marijuana-only for 
Enjoyment, Availability, and Altered Perceptions motives, and SAM for Positive Effects 
and Social motives. Similar to patterns with DMQ-R alcohol use responses, Conformity 
motives for SAM use were associated with a lower rate of SAM use frequency. SAM 
Social motives and alcohol Coping and Enhancement motives were associated with a 
higher rate of respective substance use frequency. The DMQ-R’s Social, Coping, and 
Enhancement motives were also positively associated with alcohol use-related problems. 
Higher endorsement of the CMMQ’s Alcohol motives and lower endorsement of 
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Experimentation motives predicted a greater likelihood of SAM use, while higher 
endorsement of the SAM use Calm/Coping and lower endorsement of Conformity 
motives predicted a greater likelihood of SAM use. The CMMQ’s Availability motives 
were associated with a lower rate of marijuana-only use frequency, while Boredom and 
Sleep/Rest motives were associated with a higher rate of marijuana-only use frequency. 
The SAM use Calm/Coping and Social motives were associated with a higher rate of 
marijuana use. The SAM use Conformity motives, again, predicted a lower rate of 
marijuana-only use. Finally, the CMMQ’s Conformity and Boredom motives, as well as 
the SAM use Calm/Coping motives, were positively associated with marijuana use-
related problems.  
There are two noteworthy observations from the SAM use motive measure 
development: (a) depressive and escape from negative affect states motives were not 
included in the preliminary or final item content for this SAM use motive measure and 
(b) Positive Effects appears to include content that had yet to be considered for SAM use, 
in alcohol motive measures, or marijuana motive measures (i.e., essentially managing and 
influencing the effects of other substances; e.g., “to increase the positive effects I get 
from alcohol” or “cross-faded effects are better”) but has been included in other measures 
of substance use motives. Thus, likely-relevant alcohol, marijuana, and SAM use motives 
captured in other substance-specific or broadband substance motive measures will be 
described below.   
Other Relevant Alcohol and Marijuana Motives  
Blevins, Lash, and Abrantes (2017) developed the Clinical Substance Use 
Motives Questionnaire (CSUMQ) to examine reasons for individual’s typical substance 
 
8 
of use among alcohol, opiates, and “cocaine and other stimulants” in a residential 
treatment sample. A factor analysis of the items suggested an eight-factor model: (1) 
Social/Enhancement, (2) Other Substance Use, (3) Coping with Anxiety, (4) Withdrawal, 
(5) Loneliness, (6) Pain/Sleep, (7) Coping with Depression, and (8) Relieving 
Boredom/Getting Energy. Although marijuana and SAM motives were not examined in 
this study, there are a few important findings to highlight. First, large correlations were 
found between alcohol use and both Coping with Anxiety and Coping with Depression 
motives, further suggesting both facets of coping are salient and warrant consideration. 
Second, Withdrawal content (e.g., “To avoid withdrawal symptoms”) and Other 
Substance Use motives (e.g., “To counteract the effects of other substances”), although 
parsed into separate factors in this measure, appear to capture the aforementioned theme 
of managing the effects of substances that had yet to be captured in an alcohol, 
marijuana, or SAM use motive measure. In a study of alcohol, marijuana, amphetamine, 
ecstasy, LSD, and cocaine use among young adults (aged 16 to 22 years), marijuana (44.3 
percent) and alcohol (41 percent) were the most frequently used to not only manage the 
effects of other substances but also to be used in combination with other substances for 
this reason (marijuana = 64.6%; alcohol = 35.9 percent; Boys, Marsden, & Strang, 2001). 
Individually, alcohol and marijuana use among 18-year-old high school seniors to 
increase the effects of other substances has been associated with greater frequency of use 
among each substance, respectively (Patrick, Schulenberg, O’Malley, Johnston, & 
Bachman, 2011).  
To date, substitution motives (e.g., using one substance in place of another or to 
supplement a substance when it is not available) have been considered in the synthetic 
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cannabinoid use (Loeffler, Delaney, & Hann, 2016), kratom use (Smith & Lawson, 
2017), and misuse of opioid substitution treatment motive literature (e.g., buprenorphine, 
naloxone, methadone; Schmidt et al., 2013). On the surface, motives related to 
substituting one substance for another appear to be at least minorly related to managing 
the effects of other substances. Individuals who substitute one substance for another, 
however, appear to do so to reduce or completely stop use of another substance that may 
be problematic legally, occupationally, relationally, or physiologically, to avoid detection 
from external sources (e.g., through urine screens), to counteract the effects of tolerance 
to another substance, or because they have limited access to the substance of choice. 
Alcohol and marijuana may very well each be used in substitution of another substance 
for these reasons. With the exception of marijuana being used to avoid detection on a 
drug screen, it may still be used to avoid detection otherwise by co-workers, family 
members, and peers, especially if ingested with edibles versus smoking. Further, alcohol 
may be used to substitute marijuana at or after age 21 years, given the shift to perhaps 
greater availability and statutory legality (Crost & Guerror, 2012).  
The Motivations for Using Substances Questionnaire (MUSQ) 
The MUSQ was recently developed to capture a broader range of motivations, 
broader range of substances addressed, and more nuanced facets of motivational 
constructs that had yet to be captured within a single substance use motive measure 
(Altenberger, 2020). In the pilot study of the MUSQ, participants were asked to respond 
to 112 motivation items based on past motive measures, existing motives in the literature, 
and researcher-developed motive items for a variety of substances, including alcohol, 
marijuana, opioids, stimulants, sedatives/anxiolytics, and hallucinogens/dissociatives 
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(See Appendix H in Altenberger, 2020 for the initial item set). The MUSQ motive items 
were assessed with three separate prompts in an attempt to capture salient constituents of 
motivations to use, guided by the Incentive Sensitization Theory’s differentiation of 
“wanting” and “liking” in relation to hedonistic non-pathological substance use and 
substance addiction through explicit measurement, that had thus far not been considered 
in the motive measure literature (Robinson & Berridge, 1993; Goldstein et al., 2010; 
Evans et al., 2006). First, participants rated their overall degree of Wanting, or craving, 
substances by responding to the questions, “When you think about alcohol and/or drugs, 
how intense are your cravings?” and “When you encounter a reminder about alcohol 
and/or drugs (e.g., people, places, things), how intense are your cravings?” on a 6-point 
Likert-type scale ranging from “Not at all” to “Extreme.” Consistent with other motive 
measures, participants first responded to the motive items by indicating how frequently 
they use alcohol and/or drugs for that reason or motive (1 = Never, 6 = Always; 
Frequency). New to the measurement of motivations to use substances, the MUSQ also 
assessed participants’ degree of liking and satisfaction for each item, represented by 
asking participants to rate how much they like using alcohol and/or drugs for that reason 
or motive (i.e., degree of subjective pleasure from using a substance to achieve that goal; 
1 = Not at all, 6 = Extremely; Liking) and how much that reason or motive is satisfied 
(i.e., fulfilled) when they use alcohol and/or drugs (1 = Not at all, 6 = Extremely; 
Satisfaction). 
Factor Structure of the MUSQ 
Although sample sizes for Liking and Satisfaction responses were too small for 
factor analyses, an exploratory factor analysis and item analysis of motive Frequency 
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items yielded an 84-item, 12-factor model that fit the data better than 8-, 9-, 10-, 11-, 13-, 
and 14-factor models: (1) Reduce Anxiety/Unpleasant Arousal, (2) Conformity, (3) 
Effects of Other Substances, (4) Relative Low Risk, (5) Positive Social Interactions, (6) 
Rebellion, (7) Altered Perceptions/Experiential Processes, (8) Performance/Arousal 
Enhancement, (9) Increase Positive Affect, (10) Manage Negative Social Interactions, 
(11) Reduce Negative Affect, and (12) Substitution. Ultimately, the 12-factor model 
captured 67.99 percent of the variance in motivations for substance use, and the factor-
based subscale scores demonstrated excellent internal consistencies evaluated with 
coefficient alphas and moderate to strong inter-item correlations.  
Limitations and Strengths of the MUSQ 
Due to low sample sizes in regression models of Frequency, Liking, and 
Satisfaction predicting frequency of substance use and use-related problems, solid 
conclusions could not be drawn from these analyses in the pilot study of the MUSQ’s 
psychometric properties. Further, in an attempt to develop a broadband measure of 
substance use motives across substances by asking participants to respond based on their 
overall use of “alcohol and/or drugs,” results may have been skewed toward alcohol, 
marijuana, and stimulant motives, while still muddied by other substance motives, with 
the overwhelming majority of participants identifying alcohol (81.7 percent) and 
cannabis (61 percent)  in their top three drugs of choice, followed substantially less by 
prescription stimulants (17.2 to percent), as all other substances in participants’ top three 
drugs of choice presented at much lower frequencies (i.e., .3 percent [synthetic 
cathinones] to 12.8 percent [prescription opioids]). Given the imbalanced distribution of 
substances addressed in this study, a Performance/Arousal Enhancement factor likely 
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would not have emerged otherwise. The Manage Negative Social Interactions factor 
yielded only two strong-loading items, and, upon further reflection, it was noted that one 
item (i.e., to avoid or manage conflict with others) was double-barreled and could further 
be parsed apart to potentially yield a three-item factor with stronger psychometric 
properties. Theoretically, these items could also fit with Conformity content or load 
negatively with Positive Social Interactions content with the separation and addition of a 
third item. Finally, participants responded to motive items based both on past and current 
use of substances, which likely further muddied any conclusions that could be drawn.  
With these limitations in mind, the MUSQ demonstrated several strengths in 
adding to the motive measure literature, and the pilot study allowed for clearer future 
directions with the MUSQ that will likely add to its utility in the present study. The 
MUSQ captured common motives to use that we have seen in previous motive measures, 
such as Conformity, Reduce Anxiety/Unpleasant Arousal and Reduce Negative Affect 
(Coping), Increase Positive Affect (Enhancement), Altered Perceptions/Experiential 
Processes (Expansion), and Positive Social Interactions (Social). Comparable to the 
Modified DMQ-R and CSUMQ, the MUSQ separated coping with negative affect into 
coping with anxiety (Reduce Anxiety/Unpleasant Arousal) and coping with other various 
negative affective states (Reduce Negative Affect). Other rarely considered motives also 
emerged in the MUSQ that warrant consideration and further inspection. First, Rebellion 
emerged as a salient factor from the MUSQ pilot data, which not only has been seldom 
considered in substance use motives but also did not emerge in the final factor structure 
of the CMMQ, suggesting these motives may be more relevant for other substances, such 
as alcohol or SAM use. Second and unique to the MUSQ, social interaction motives 
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separated into two distinct factors that measured using to mitigate negative social 
interactions (Manage Negative Social Interactions) and using to experience positive 
social interactions (Positive Social Interactions). Finally, to the author’s knowledge, 
Effects of Other Substances, Relative Low Risk, Altered Perceptions/Experiential 
Processes, and Substitution content emerged from a factor analysis for the first time in a 
single comprehensive substance use motive measure – content that would arguably be 
important in assessing alcohol-only, marijuana-only, and SAM use beyond what 
assessment tools are available to date.   
The Present Study 
Given the limitations and strengths of the initial study of the MUSQ, as well as 
the growing concern for further understanding characteristics of SAM use and how they 
compare to alcohol- and marijuana-only use, there were four major aims of this study. 
The present psychometric study proposed to further examine motivations to use across 
these three groups of users to determine whether and where they differ through 
evaluation of the measurement invariance of the MUSQ. By using the most 
comprehensive questionnaire assessing motivations to use at this time, the MUSQ was 
expected to capture more nuanced and critical information on individuals’ reasons for 
using alcohol, marijuana, and both simultaneously, adding to the construct validity by 
examining how these patterns relate to frequency of use and use-related problems. 
Finally, this study addressed limitations and build on the results of the pilot MUSQ study 
by soliciting responses based on current (i.e., past month) substance use and specifying 
which substances (or combination of substances) were to be referenced in completing the 
measure to provide more clarity in the relationships between motives and substances. 
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Further, limitations of the two-item factor, Manage Negative Social Interactions, were 
addressed by separating a double-barreled item and determining whether this factor held 
as a separate factor or fit better with an alternative factor (i.e., Conformity or negatively 
with Positive Social Interactions). This adjustment would ideally allow for the 
recommended minimum of three indicators per factor to test invariance should the factor 
hold (Byrne, Shavelson, & Muthen, 1989; MacCallum, 1995).  
Hypotheses 
Hypothesis 1: Frequency of Use Predicting Use-Related Problems 
1. Frequency of alcohol- and marijuana-only use would positively predict alcohol-
related and marijuana-related problems, respectively. 
2. Frequency of SAM use would predict greater alcohol-related and marijuana-
related problems than frequency of alcohol- and marijuana-only use.  
Hypothesis 2: Confirmatory Factor Analysis (CFA) Models 
1. With the potential exception of Managing Negative Social Interactions content, it 
was expected that the original MUSQ factor model would fit the data for alcohol-
only, marijuana-only, and SAM users’ responses.  
2. In testing the baseline model fit for Managing Negative Social Interactions 
content by separating a double-barreled item into two items, it was hypothesized 
that this would allow for stronger psychometric properties of this factor (i.e., 
coefficient alphas) and allow the items to continue loading together in this latent 
variable.  
3. Alternatively, these items could fit models better under the Conformity latent 
variable or negatively with the Positive Social Interactions latent variable.  
 
15 
Hypothesis 3: Internal Consistency of the MUSQ Scales 
Consistent with the psychometric properties of the MUSQ in the pilot study, it 
was hypothesized that good internal consistency reliability of the factor-derived subscales 
would be observed from the baseline CFA models.   
Hypothesis 4: Measurement Invariance of the MUSQ Across Substance Groups 
It was hypothesized that the MUSQ would demonstrate configural invariance 
(same number of factors), metric invariance (equivalent factor loadings), and scalar 
invariance (equivalent item intercepts) across the three groups. While full scalar variance 
is difficult to achieve, it was expected that this level of invariance would at least be met at 
a partial invariance level.  
Hypothesis 5: Mean Differences in MUSQ Latent Factors 
It was hypothesized that there would be differing degrees of salience of motives 
across each substance group. The following were predictions for latent means: 
1. Several common underlying motive means would not significantly differ across 
all three substance groups: (1) Reduce Anxiety/Unpleasant Arousal, (2) 
Conformity, (3) Effects of Other Substances, (4) Positive Social Interactions, (5) 
Increase Positive Affect, and (6) Reduce Negative Affect.  
2. Two motives, Relative Low Risk and Rebellion, would not demonstrate 
significantly different means for alcohol- and marijuana-only use comparisons, 
but alcohol- and marijuana-only users would demonstrate significantly higher 
means for Relative Low Risk and Rebellion than SAM users.  
3. Marijuana-only users would demonstrate significantly higher means for Altered 
Perceptions/Experiential Processes compared to alcohol-only and SAM users.  
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4. Given the novel and rare examination of Substitution and Manage Negative 
Social Interactions content, group mean difference testing would be exploratory.  
Hypothesis 6: MUSQ Motives Predicting Use-Related Problems 
Irrespective of which substance group was referenced in MUSQ responses: 
1. Several motives would predict more problems: (1) Reduce Anxiety/Unpleasant 
Arousal, (2) Positive Social Interactions, (3) Increase Positive Affect, and (4) 
Reduce Negative Affect.  
2. Conformity would negatively predict problems. 
3. Altered Perceptions/Experiential Processes would either negatively predict or not 
contribute to the prediction of use-related problems. 
4. Evaluation of the salience and directionality of all other motives in this model 
(i.e., Rebellion, Substitution, Relative Low Risk, Manage Negative Social 




CHAPTER II – METHODOLOGY 
IRB Statement 
Collection of data was initiated after approval by The University of Southern 
Mississippi’s Institutional Review Board (see Appendix for IRB approval letter). 
Participants 
Participants were recruited from an undergraduate psychology research pool at a 
medium-sized Southeastern United States university. Participants were also recruited 
from social media outlets (e.g., Facebook, Reddit). Individuals 18 years of age or older 
who had used marijuana or alcohol in the past 30 days were invited to participate. Ideally, 
we aimed to recruit 675 participants (225 alcohol-only, 225 marijuana-only, and 225 
SAM users) based on Kelloway (2014) and Anderson and Gerbing’s (1984) 
recommendations for sample sizes > 200 for models that make use of three indicators per 
latent variable; however, the literature suggests marijuana-only users are a relatively 
smaller population (e.g., Meda et al., 2017). 
Skalisky, Wielgus, Aldrich, & Mezulis, 2018) and prevalence rates for 
simultaneous use are approximately twice the rate of concurrent use (Subbaraman & 
Kerr, 2015). Therefore, although we expected our sample to be limited in power to 
examine marijuana-only users, we aimed to address this limitation by soliciting 
marijuana-only motive responses from both those who used marijuana only and those 






Frequency of Substance Use 
First, participants indicated their current alcohol and marijuana use statuses (i.e., 
“Have you used alcohol in the past 30 days?”; “Have you used marijuana in the past 30 
days?”). For those who indicated they had recently used both, participants were asked to 
indicate whether alcohol and marijuana were used simultaneously (i.e., “In the past 30 
days, have you used alcohol and marijuana simultaneously [i.e., co-ingested them in the 
same sitting or used within a time frame that allowed you to feel the effects of both]?”). 
Dichotomous yes/no responses were coded (i.e., 1 = Yes, 2 = No).  
For each substance use status group (alcohol-only, marijuana-only, and SAM 
users), we assessed frequency of use with the question, “On how many occasions have 
you [only used alcohol; only used marijuana; used alcohol and marijuana simultaneously 
(i.e., co-ingested them in the same sitting or used within a time frame that allowed you to 
feel the effects of both)] in the past 30 days?” (1 = Once, 2 = Twice, 3 = 3-5 occasions, 4 
= 6-9 occasions, 5 = 10-15 occasions, 6 = 16 to 20 occasions, 7 = 21-31 occasions, 8 = 32 
or more occasions). We also assessed frequency of binge drinking with the question, “On 
how many occasions have you had five [men] or four [women] more drinks in a row in 
the past 30 days?” depending on the identified sex of the participant based on the 
National Institute of Alcohol Abuse and Alcoholism definition of binge drinking 
(NIAAA, 2004). We utilized the same response scale from the frequency of use question 






Alcohol use-related problems were assessed with the Rutgers Alcohol Problem 
Index (RAPI; White & Labouvie, 1989). The RAPI is an 18-item questionnaire that 
assesses the frequency at which individuals have experienced a broad range of problems 
that have occurred while drinking or because of drinking in the last year. Responses are 
rated on a 5-point Likert-type scale (0 = Never, 1 = 1-2 times, 2 = 3-5 times, 3 = 6-10 
times, 4 = More than 10 times). Although initially developed for adolescent populations, 
the RAPI has been validated with adults (Larimer et al., 2001; Marlatt et al., 1998). The 
RAPI yields a summed total score with no reverse coded items. Marijuana use-related 
problems were similarly assessed with a parallel version of the RAPI – the Marijuana 
Problem Index (MPI; Johnson & White, 1989; Knapp, 2017). Both outcome measures 
have been utilized extensively within the motive measure literature (e.g., Simons, 
Correia, Carey, & Borsari, 1998; Simons, Gaher, Correia, Hansen, & Christopher, 2005; 
Lee, Neighbors, & Woods, 2007; Martens, Rocha, Martin, & Serrao, 2008). 
Motivations to Use  
To assess motivations to use, participants completed the Motivations for Using 
Substances Questionnaire (MUSQ; Altenberger, 2020). The MUSQ is an 84-item self-
report broadband measure that was recently developed to assess individuals’ reasons for 
overall substance use. The MUSQ yielded a 12-factor model: (1) Reduce 
Anxiety/Unpleasant Arousal (i.e., RAUA; e.g., “To calm down,” “To release tension,” 
“To stop worrying”); (2) Conformity (i.e., CNF; e.g., “To avoid feeling rejected,” “To not 
be the only one not doing it”); (3) Effects of Other Substances (i.e., EOS; e.g., “To reduce 
the effects of, or ‘come down’ off of another drug,” “To enhance the effects of another 
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drug”); (4) Relative Low Risk (i.e., RLR; e.g., “Because it is more socially acceptable 
than other drugs,” “Because it does not cause me as many problems as other drugs,” 
“Because it is not as bad for you as other drugs”); (5) Positive Social Interactions (i.e., 
PSI; e.g., “To lose my inhibitions in social situations,” “To make social gatherings and 
parties more fun,” “To help me relate to others better”); (6) Rebellion (i.e., REB; e.g., 
“To experience the thrill of doing something I’m not supposed to do,” To rebel against 
authority or society”); (7) Altered Perceptions/Experiential Processes (i.e., APEP; e.g., 
“To alter how I perceive my environment [e.g., hear music in greater detail or 
complexity; enhance or dull sensations; drown out distractions],” “To seek new 
experiences,” “To cause me to perceive things that are not present [i.e., to hallucinate; to 
see patterns or distortions that are not actually present]”); (8) Performance/Arousal 
Enhancement (i.e., PAE; e.g., “To focus or pay attention,” “To stay awake,” “To perform 
better on school [or occupational] work/tests”); (9) Increase Positive Affect (i.e., IPA; 
e.g., “To have fun,” “To feel more self-confident or effective,” “To feel less bored”); (10) 
Manage Negative Social Interactions (i.e., MNSI; e.g., “To avoid hurting someone’s 
feelings”); (11) Reduce Negative Affect (i.e., RNA; e.g., “To forget, escape, or avoid my 
memories,” “To reduce feelings of hopelessness”); and (12) Substitution (i.e., SUB; e.g., 
“To use a drug that is more powerful than one I have gotten used to,” “To get the same 
effects as something I’m prescribed when I run out of my prescription”). Cronbach’s 
alphas for the original sample ranged from .85 (MNSI) to .95 (PSI). For the purposes of 
the current study, we dropped the four items from the PAE subscale as they were 
primarily included in this broadband measure to capture more functionally stimulating 
substance use based on content from the Prescription Stimulant Motives Scale (Blevins, 
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Stephens, & Abrantes, 2016). Further, we separated one MNSI item (“To avoid or 
manage conflict with others”) into two items: “To avoid conflict with others” and “To 
manage conflict with others.” 
The MUSQ was initially developed to have participants rate their overall intensity 
of wanting, or craving, intensity with two items (Wanting) and subsequently respond to 
each motive item three times – once for frequency of use (Frequency), once for the 
degree to which participants like that they use substances for that motive (i.e., to achieve 
that goal; Liking), and once for the degree to which that motive or goal is satisfied via 
substance use (Satisfaction). While examining all four constructs in relation to alcohol-
only, marijuana-only, and SAM use will likely prove beneficial in future examinations of 
the MUSQ and in further specifying individualized interventions, the current study 
focused on the measurement structure of ratings of frequency of use for the various 
motivations. This would build on and expand the existing research on this dimension 
measured by the MUSQ. As such, only the Frequency portion of the MUSQ was 
administered. Specifically, Frequency on the MUSQ was measured by asking participants 
to “Rate the following reasons or motives for your use of alcohol and/or drugs on how 
frequently you use alcohol and/or drugs for that reason or motive.” Responses were 
recorded on a 6-point Likert-type scale (1 = Never; 2 = Rarely; 3 = Occasionally; 4 = 
Often; 5 = Almost Always; 6 = Always). To reflect the aim of this study, we replaced 
“use of alcohol and/or drugs” with “use of alcohol by itself,” “use of marijuana by itself” 
and “use of alcohol and marijuana simultaneously, such that the effects overlap.” Scale 
scores were calculated from the mean of the items that comprise that scale following 
confirmatory factor analysis and invariance testing.  
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Design and Procedure 
Participants were recruited through a research participant pool in the School of 
Psychology at a Southeastern university as well as advertisement in appropriate social 
media outlets. Participants recruited from the Southeastern university registered for the 
study through an online research participation management system (SONA). Potential 
participants who indicated a willingness to participate by signing up for the study through 
SONA subsequently received an email with a web link to complete the online 
questionnaire generated through Qualtrics, which included the informed consent 
document and required indication of consent through a check box in order to proceed 
with the study. Those recruited through social media outlets were prompted to either (a) 
copy the posted web link into an internet browser or (b) scan the QR code with a 
smartphone that would open a web browser to the study on the Qualtrics web site.  
First, participants were prompted to review an informed consent document 
detailing the anonymity of responses, voluntary nature of participation, and local mental 
health services’ contact information, for those who may have concerns about their 
substance use and/or experience any distress from completing the questionnaires. 
Participants indicated their consent by clicking a checkbox that states “I consent.” 
Participants who clicked the checkbox that states “I do not consent” were exited out of 
the Qualtrics survey and did not receive credit or have the opportunity to enter into the 
survey completion drawing. Participants responded to general demographic questions 
(e.g., age, race/ethnicity, education, gender identity, etc.) and reported their frequency of 
past 30-day use of alcohol and marijuana. Of those who endorsed recent use of both 
substances, skip logic led participants to indicate whether they have used SAM within the 
 
23 
past 30 days and, if so, indicate their frequency of recent SAM use. Next, skip logic 
prompted participants to complete the motive Frequency scales of the Motivations to Use 
Substances Questionnaire (MUSQ) in reference to the substance classes they endorsed 
for recent use (i.e., alcohol-only, marijuana-only, concurrent alcohol and marijuana use, 
or SAM use). Therefore, alcohol-only users completed the MUSQ once based on their 
reasons for alcohol use; marijuana-only users and those who endorsed recent alcohol and 
marijuana use, but not SAM use, completed the MUSQ once based on their reasons for 
marijuana use; and those who endorsed SAM use completed the MUSQ in reference to 
SAM use. Following completion of the MUSQ, skip logic prompted participants to 
complete RAPI and MPI measures, as indicated. Following completion of the measures, 
participants that were not participating for course credit or extra credit were prompted to 
enter their email to be entered into the drawing for one of four (4) $25.00 Amazon e-gift 
cards. Participants recruited through SONA received compensation through course credit 
or extra credit. Measurement invariance was tested using a structural equation modeling 
(SEM) framework (Rensvold & Cheung, 1998; Steenkamp & Baumgartner, 1998; 
Vandenberg & Lance, 2000). 
Statistical Plan 
Data Preparation 
Participants’ responses were screened for random responding through five 
validity checks. With these items, participants were asked to select a specific response 
(e.g., “Please choose the ‘never’ option”). Participants’ responses were considered valid 
if at least three of the five checks were passed.  
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MUSQ motive Frequency items were assessed for frequency of missing data to 
determine if the frequency of missing data for an item was high (i.e., 10 percent or 
higher). Items with missing at a high frequency were examined for trends of random or 
systematically missing data to note in the results. Specifically, data not missing at random 
would warrant further examination (Enders, 2010). Due to the nature of a forced-choice 
online data collection format, the data did not necessitate screening for out-of-range 
values. Further, because of the ordinal nature of Likert-type responses collected for the 
variables of interest and the meaningfulness of analyzing all individuals’ responses (even 
at the extremes), tests of skewness and kurtosis were not used. In addition, the use of 
confirmatory factor analysis (CFA) estimates has no assumption of normality among the 
data. 
Hypothesis 1: Frequency of Use Predicting Use-Related Problems 
To test the hypothesized relationships between frequency of use and use-related 
problems, we conducted four linear regression analyses. Past 30-day alcohol use, 
marijuana use, and SAM use served as individual independent variables. RAPI scores 
served as the dependent variable for frequency of alcohol use; MPI scores served as the 
dependent variable for frequency of marijuana use; and frequency of SAM use was 
entered into two separate regressions predicting RAPI and MPI scores. To correct for 
Type I error, a Bonferroni correction of p < .01 was utilized (Bonferroni, 1936).  
Hypothesis 2: Confirmatory Factor Analysis (CFA) Models 
Model Identification. Confirmatory factor models were estimated with M-Plus 
Version 8.2 (Muthén & Muthén, 1998-2011) using the covariance matrix as the matrix of 
associations that was analyzed. A 11-factor model and two 10-factor models (i.e., testing 
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the fit for MNSI items on CNF and PSI latent variables) were tested separately for the 
alcohol-only and SAM motive groups. This analysis allowed the theoretical model 
derived in the pilot study of the MUSQ to be tested against the observed data in this 
study. To identify the model and set the scale, the loading for the first item from each 
factor was fixed to unity and variances of item residuals were fixed to unity.  
Model Fit. We evaluated several indices to determine model fit. Acceptable 
model fit was considered with Comparative Fit Index (CFI; Bentler, 1990) values greater 
than or equal to .90 and Root Mean Square Error of Approximation (RMSEA; Steiger & 
Lind, 1980) values less than or equal to .10 (Weston & Gore, 2006). Excellent fit was 
considered with CFI values .95 or higher and .06 or lower for RMSEA (Hu & Bentler, 
1999) The chi-square test statistic was not used as a goodness-of-fit statistic due to its 
sensitivity to sample size (Bentler & Bonnet, 1980); however, it was reported for as per 
the standard convention for CFA results. For models with less than acceptable fit, we 
examined standardized factor pattern coefficients of items on hypothesized factors and 
associated modification indices to determine whether theoretically relevant post-hoc 
modifications could be made to the model to achieve acceptable fit and determine the 
most appropriate baseline model. Given the data were likely to be skewed and the MUSQ 
response format yields ordinal data, models were run using the weighted least squares 
mean and variance adjusted (WLSMV) estimation.  
Hypothesis 3: Internal Consistency of the MUSQ Scales 
Upon determining the baseline model, we evaluated internal consistency of the 
MUSQ factor-derived subscales. Internal consistency reliability was evaluated for 
 
26 
alcohol-only, marijuana-only, and SAM groups, as well as the total sample, using 
Cronbach’s alpha and computation of the range and mean of item-scale correlations.  
Hypothesis 4: Measurement Invariance of the MUSQ Across Substance Groups 
Criteria Used to Evaluate Fit. Measurement invariance of the MUSQ was tested 
using the first three (of four) sequentially restrictive steps described by Widaman and 
Reiss (1997) reflecting tests of (1) configural, (2) metric, and (3) scalar invariance. The 
fourth step, testing invariance of residuals, was excluded from analyses because it is not 
necessary for, and does not have an effect on, examining differences in latent means 
(Vandenberg & Lance, 2000). A series of nested multiple group confirmatory factor 
analysis (MGCFA) models with sequentially greater numbers of group invariance 
constraints were estimated using M-Plus Version 8.2 (Muthén & Muthén, 1998-2011). 
The best-fitting model identified in the individual group CFAs was used as the baseline 
model. To test for measurement invariance across groups, the fit indices used to evaluate 
the models in the baseline CFAs (CFI and RMSEA) were also examined in all tests of 
invariance. In addition, the difference in fit of the more constrained model was compared 
with that of the next less constrained model. Evidence for non-invariance was assessed by 
a decrease in CFI greater than or equal to .01 and an increase in RMSEA of .015 or 
greater (Chen, 2007). The chi-square difference test statistics were reported, although 
they were not used as criteria for measurement invariance due to their sensitivity to 
sample sizes. Chi-square statistics that yield a nonsignificant value simply suggest 
insufficient information to reject the null hypothesis, which does not then indicate 
equivalence, per se (Cheung & Rensvold, 2002; Counsell, Cribbie, & Flora, 2020). To 
identify the models, one factor pattern coefficient per factor was fixed to unity in both 
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groups. For mean structure analyses, the latent factor means were fixed to zero in one 
group and freed for estimation in the comparison group. 
Configural Invariance. Configural invariance was tested to determine whether the 
pattern of loadings of items on the MUSQ latent factors was invariant across substance 
groups (i.e., alcohol-only and SAM users). For this multiple-groups model, the baseline 
model was tested with the two groups simultaneously, with the same number of factors 
and same pattern of zero and non-zero loadings, but with no equality constraints on the 
values of any of the model parameters.  
Metric Invariance. If configural invariance is achieved, metric invariance can be 
tested to determine whether items contribute to the MUSQ latent factors to the same 
degree across groups. To test this level of invariance, equality constraints are placed on 
matched-item factor loadings across groups. The fit of the metric model is compared to 
the fit of the configural model. If the fit of the metric model is not worsened to a notable 
degree compared to the configural model (i.e., ΔRMSEA ≥ .015, ΔCFI ≤ .01), it is 
concluded that metric invariance is demonstrated. If passed, invariance at this level 
suggests that any group differences in factor variances and covariances are true 
differences due to group membership, not a bias in measurement.   
Scalar Invariance. If metric invariance is achieved, scalar invariance can be tested 
to establish whether item thresholds differ across groups. To test this level of invariance, 
equality constraints are placed on matched-item intercepts across groups. The fit of the 
scalar model is compared to the fit of the metric model. If the fit of the scalar model is 
not worsened to a notable degree compared to the metric model (i.e., ΔRMSEA ≥ .015, 
ΔCFI ≤ .01), it is concluded that scalar invariance is demonstrated. If this level of 
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invariance is passed, differences in latent factor means can be concluded to be due to true 
differences across groups rather than a bias in measurement.  
Partial Invariance. In the event of evidence for non-invariance, partial invariance 
is considered at the metric and scalar level in order to allow for examination of 
subsequent mean differences among the latent factors using only those factors that are 
deemed at least partially invariant. Partial invariance is determined by examining the 
sources of non-invariance through modification indices and sequentially releasing 
constraints (on the factor loadings or thresholds) until a partially invariant model emerges 
(Jung & Yoon, 2016). Partial invariance is passed if the majority of items on a factor are 
invariant (Steenkamp & Baumgartner, 1998; Vandenberg & Lance, 2000). 
Hypothesis 5: Mean Differences in MUSQ Latent Factors 
If scalar invariance is demonstrated, group latent factor means are compared by 
setting the latent factor variance to zero for one group and allowing the same latent factor 
in the respective comparison group to vary. The standardized mean in the comparison 
group, if statistically significant, represents the standard deviation difference in the 
comparison group relative to the reference group (Putnick & Bornstein, 2016).  
Hypothesis 6: MUSQ Motives Predicting Use-Related Problems 
To determine whether endorsement of substance-class-specific MUSQ motive 
Frequency scales predict use-related problems, we conducted four multiple regressions. 
For the first model, MUSQ motive Frequency scales completed in reference to alcohol 
use served as the independent variables and RAPI scores served as the dependent 
variable. For the second model, Marijuana MUSQ motive Frequency scales were 
independent variables and MPI scores were the dependent variable. For the third and 
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fourth models, SAM Motive Frequency scales served as independent variables predicting 
RAPI and MPI scores in separate analyses. To correct for Type I error, a Bonferroni 
correction of p < .01 was utilized. These analyses, if the hypothesis is supported, 
provided initial evidence for the construct validity of the MUSQ scale scores.   
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CHAPTER III – RESULTS   
Data Preparation 
Of the total sample of those who consented to the study (N = 1670), 21 
participants were excluded due to indicating they were under the age of 18 years. Ninety 
participants were excluded due to indicating they had not used alcohol or marijuana in the 
past month. Finally, an additional 549 responses were excluded from analyses due to 
failure to pass validity checks. Thus, the final sample consisted of 1010 participants (see 
Table 1 for demographic characteristics). As expected, there were significantly more 
past-month alcohol users (n = 461) and SAM users (n = 374) than marijuana-only and 
concurrent alcohol and marijuana users (n = 175). Despite efforts to recruit and capture a 
marijuana subsample, this group was underpowered for CFA and invariance testing 
analyses to interpret meaningful results. As such, two-group (alcohol [i.e., ALC] and 
SAM) difference testing was conducted. 
Table 1 Demographics 
 n % Min Max M SD 
Age   18 71 24.56 7.34 
Gender       
     Female 562 55.6     
     Male 404 40.0     
     Genderqueer / gender 
non-conforming  
18 1.8     
     Cisgender 8 0.8     
     Transman 5 0.5     
     Other 5 0.5     
     Prefer not to say 5 0.5     






Table 1 (continued). 
Marital Status       
     Single 725 71.8     
     Married 176 17.4     
     Engaged 60 5.9     
     Divorced 23 2.3     
     Prefer not to say 20 2.0     
     Separated 4 0.4     
     Widowed 2 0.2     
Race / Ethnicity       
     White 676 66.9     
     Black 130 12.9     
     Other / biracial / 
multiracial 
58 5.7     
     American Indian / 
Alaska Native 
44 4.4     
     Hispanic / Spanish / 
LatinX 
42 4.2     
     East Asian / Asian 
American                                 
25 2.5     
     Prefer not to say 13 1.3     
     South Asian / Indian 
American 
12 1.2     
     Middle Eastern / 
Arab American 
9 0.9     
     Pacific Islander 1 0.1     
Education       
     Some college, no 
degree 
428 42.4     
     Bachelor’s degree 173 17.1     
     Graduated high 
school or equivalent 
166 16.4     
     Associate degree 130 12.9     
     Master’s degree 56 5.5     
     12th grade or less 28 2.8     
     Doctoral or 
professional degree 
16 1.6     
     Prefer not to say 13 1.3     
Recruitment Method       
     Social media 572 56.6     




Next, we examined frequencies for all variables of interest (i.e., frequency of use, 
MUSQ items, and RAPI and MPI items by respective substance group; Table 2). No 
variables were missing more than ten percent of data. Frequencies of missing MUSQ 
item data ranged from 0.2 to 1.4 percent. Frequencies of missing frequency of use data 
ranged from 0.0 to 0.2 percent. Frequencies of missing RAPI and MPI items ranged from 
0.9 to 4.8 percent and 2.9 to 7.0 percent, respectively. Therefore, none warranted 
exclusion or further examination. 
Table 2 Descriptive Statistics for Variables of Interest 
 n % Min Max M SD  
Substance group        
     ALC 461 45.6      
     Marijuana 175 17.3      
     SAM 374 37.0      
RAPI        
     Total across groups 1053  0.0 72.0 14.20 13.59 .957 
MPI        
     Total across groups 676  0.0 72.0 16.98 13.69 .933 
Alcohol group        
     Frequency of use 461  1.0 8.0 3.35 1.52  
     Frequency of binge 
drinking 
459  0.0 7.0 1.75 1.57  
     RAPI 440  0.0 59.0 8.81 11.16 .950 
Marijuana group        
     Frequency of use 175  1.0 8.0 4.41 2.66  
     MPI 163  0.0 50.0 9.91 11.02 .900 
SAM group        
     Frequency of use 374  1.0 8.0 2.90 1.62  
     RAPI 340  0.0 66.6 14.10 13.26 .944 
     MPI 336  0.0 62.0 16.13 13.13 .920 
Abbreviations: ALC, alcohol group; SAM, simultaneous alcohol and marijuana users; RAPI, Rutgers Alcohol Problem Index; MPI, 




Hypothesis 1: Frequency of Use Predicting Use-Related Problems 
We conducted four linear regression analyses to test the hypothesized 
relationships between frequency of use and use-related problems. Table 3 presents the 
results of the analyses. For the models, sample sizes ranged from 336 to 780. All models 
were statistically significant with a Bonferroni correction of p < .01.  Past-month 
frequency of alcohol use accounted for 26.5 percent of the variance in alcohol use-related 
problems. Past-month frequency of marijuana use accounted for 6.5 percent of the 
variance in marijuana use-related problems. Finally, past-month SAM use accounted for 
9.8 and 11.4 percent of the variance in marijuana and alcohol use-related problems, 
respectively. Standardized betas ranged from .255 to .515. As expected, greater frequency 
of use predicted a greater degree of associated substance use problems.  
Table 3 Linear Regression Analyses for Frequency of Use Predicting Use-Related 
Problems 
Note: * Significant with Bonferroni correction of p < .01 
Abbreviations: SAM, simultaneous alcohol and marijuana users; RAPI, Rutgers Alcohol Problem Index; MPI, Marijuana Problem 
Index.  
 n R2 B SE B β t p 
Model 1 (RAPI) 780 .265     <.001* 
     (constant)   -1.973 .869  -2.271 .023 
     Alcohol Use Frequency   3.781 .226 .515 16.761 <.001* 
Model 2 (MPI) 498 .065     <.001* 
     (constant)   7.942 1.191  6.669 <.001* 
     Marijuana Use Frequency   1.377 .235 .255 5.873 <.001* 
Model 3 (RAPI) 340 .114     <.001* 
     (constant)   6.083 1.390  4.378 <.001* 
     SAM Use Frequency   2.802 .424 .338 6.610 <.001* 
Model 4 (MPI) 336 .098     <.001* 
     (constant)   8.747 1.404  6.230 <.001* 
     SAM Use Frequency   2.548 .423 .313 6.018 <.001* 
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Hypothesis 2: Confirmatory Factor Analysis (CFA) Models 
For the hypothesized 11-factor and two 10-factor models, all of the resulting 
latent variable covariance matrices were non-positive definite. Non-positive definite 
latent variable covariances can be due to negative factor variance or linear dependency 
among two or more of the latent factors (Wothke, 1993). We requested the M-Plus “Tech 
4” output for the models in order to investigate the reason for the non-positive definite 
matrices. All factor variances were positive and non-zero. Next, we examined the latent 
factor correlations which are presented in Tables 4-9. There were high correlations across 
most of the latent factors. As outlined below, frequency and magnitude of high 
correlations among the latent factors suggested a higher-order motivation factor. 
In the 11-factor model, correlations among the latent factors for the SAM group 
ranged from .492 to .952, with 11 latent factor correlations .85 or higher (Table 4). Latent 
factor correlations for the ALC group ranged from .603 to .993, with 21 correlations .85 
or higher (Table 5). In the 10-factor model combining indicators for MNSI and PSI, 
correlations among the latent factors for the SAM group ranged from .492 to .952, with 
eight latent factor correlations .85 or higher (Table 6). Latent factor correlations for the 
ALC group ranged from .604 to .993, with 20 correlations .85 or higher (Table 7). 
Finally, in the hypothesized 10-factor model combining indicators for MNSI and CNF, 
correlations among the latent factors for the SAM group ranged from .492 to .952, with 
eight correlations .85 or higher (Table 8). Latent factor correlations for the ALC group 




Table 4 SAM Latent Factor Correlations for Hypothesized 11-Factor Model 
 
 
Abbreviations: SAM, simultaneous alcohol and marijuana users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; CNF, factor 2, Conformity; EOS, factor 3, Effects of Other Substances; RLR, 
factor 4, Relative Low Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential Processes; IPA, factor 8, Increase Positive Affect; 







 RAUA CNF EOS RLR PSI REB APEP IPA MNSI RNA SUB 
RAUA ---           
CNF .528 ---          
EOS .520 .841 ---         
RLR .561 .683 .712 ---        
PSI .619 .903 .723 .640 ---       
REB .492 .892 .837 .648 .791 ---      
APEP .632 .869 .815 .703 .852 .856 ---     
IPA .833 .612 .572 .593 .856 .602 .781 ---    
MNSI .665 .884 .824 .638 .793 .817 .795 .634 ---   
RNA .830 .807 .719 .649 .749 .717 .724 .793 .829 ---  
SUB .534 .915 .952 .691 .740 .881 .824 .527 .849 .760 --- 
 
 
Table 5 ALC Latent Factor Correlations for Hypothesized 11-Factor Model 
Abbreviations: ALC, alcohol-only users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; CNF, factor 2, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low 
Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential Processes; IPA, factor 8, Increase Positive Affect; MNSI, factor 9, Manage 








 RAUA CNF EOS RLR PSI REB APEP IPA MNSI RNA SUB 
RAUA ---           
CNF .688 ---          
EOS .621 .836 ---         
RLR .716 .814 .886 ---        
PSI .759 .859 .636 .734 ---       
REB .682 .854 .877 .852 .732 ---      
APEP .747 .867 .879 .854 .816 .876 ---     
IPA .885 .729 .603 .778 .900 .730 .821 ---    
MNSI .712 .897 .906 .798 .763 .836 .907 .707 ---   
RNA .887 .831 .819 .796 .735 .781 .856 .858 .876 ---  
SUB .615 .869 .993 .884 .678 .884 .921 .609 .920 .826 --- 
 
 
Table 6 SAM Latent Factor Correlations for Hypothesized 10-Factor Model (MNSI+PSI) 
Abbreviations: SAM, simultaneous alcohol and marijuana users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; CNF, factor 2, Conformity; EOS, factor 3, Effects of Other Substances; RLR, 
factor 4, Relative Low Risk; MNSI+PSI, factor 5, Manage Negative Social Interactions and Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential 








 RAUA CNF EOS RLR MSNI + 
PSI 
REB APEP IPA RNA SUB 
RAUA ---          
CNF .528 ---         
EOS .520 .841 ---        
RLR .561 .683 .712 ---       
MNSI + 
PSI 
.655 .933 .787 .664 ---      
REB .492 .892 .837 .648 .832 ---     
APEP .632 .869 .815 .703 .869 .856 ---    
IPA .833 .612 .572 .593 .839 .602 .782 ---   
RNA .830 .807 .719 .648 .804 .717 .724 .793 ---  
SUB .534 .915 .952 .691 .812 .881 .824 .527 .760 --- 
 
 
Table 7 ALC Latent Factor Correlations for Hypothesized 10-Factor Model (MNSI+PSI) 
Abbreviations: SAM, simultaneous alcohol and marijuana users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; CNF, factor 2, Conformity; EOS, factor 3, Effects of Other Substances; RLR, 
factor 4, Relative Low Risk; MNSI+PSI, factor 5, Manage Negative Social Interactions and Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential 







 RAUA CNF EOS RLR MSNI + 
PSI 
REB APEP IPA RNA SUB 
RAUA ---          
CNF .688 ---         
EOS .621 .836 ---        
RLR .716 .814 .886 ---       
MNSI + 
PSI 
.776 .898 .779 .776 ---      
REB .682 .854 .877 .852 .790 ---     
APEP .747 .867 .879 .854 .871 .876 ---    
IPA .885 .729 .604 .778 .897 .730 .821 ---   
RNA .887 .831 .819 .796 .805 .781 .856 .858 ---  
SUB .615 .869 .993 .884 .809 .884 .921 .610 .826 --- 
 
 
Table 8 SAM Latent Factor Correlations for Hypothesized 10-Factor Model (MNSI+CNF) 
 
 
Abbreviations: SAM, simultaneous alcohol and marijuana users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; MNSI+CNF, factor 2, Manage Negative Social Interactions and Conformity; 
EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential 






 RAUA MNSI + 
CNF 
EOS RLR PSI REB APEP IPA RNA SUB 
RAUA ---          
MNSI + 
CNF 
.593 ---         
EOS .520 .856 ---        
RLR .561 .685 .712 ---       
PSI .620 .893 .723 .640 ---      
REB .492 .890 .837 .648 .791 ---     
APEP .632 .867 .815 .703 .852 .856 ---    
IPA .833 .635 .572 .593 .856 .602 .781 ---   
RNA .830 .835 .719 .649 .749 .717 .724 .793 ---  
SUB .535 .917 .952 .691 .740 .881 .824 .527 .760 --- 
 
 







Abbreviations: SAM, simultaneous alcohol and marijuana users; RAUA, factor 1, Reduce Anxiety / Unpleasant Arousal; MNSI+CNF, factor 2, Manage Negative Social Interactions and Conformity; 
EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential 
Processes; IPA, factor 8, Increase Positive Affect; RNA, factor 9, Reduce Negative Affect; SUB, factor 10, Substitution.  
 RAUA MNSI + 
CNF 
EOS RLR PSI REB APEP IPA RNA SUB 
RAUA ---          
MNSI + 
CNF 
.713 ---         
EOS .621 .887 ---        
RLR .716 .827 .886 ---       
PSI .759 .848 .636 .734 ---      
REB .682 .868 .877 .852 .732 ---     
APEP .747 .905 .879 .854 .816 .876 ---    
IPA .885 .738 .603 .778 .900 .730 .821 ---   
RNA .887 .869 .819 .796 .735 .781 .856 .858 ---  
SUB .615 .912 .993 .884 .678 .884 .921 .609 .826 --- 
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More detailed examination of the latent variable relationships revealed a very 
large and consistent correlation between factor 3 (Effects of Other Substances; EOS) and 
factor 11 (Substitution; SUB) for the SAM group (r = .952) and ALC group (r = .993), 
suggesting the items in these factors may theoretically represent the same underlying 
latent variable (i.e., broadly managing the effects of substances). Anchoring items from 
these factors under one latent variable in 10-factor models nevertheless continued to 
produce a non-positive definite covariance matrix. We then examined the hypothesized 
alternative models (i.e., 9-factor models testing fit for MNSI indicators on the Positive 
Social Interactions [PSI] and on the Conformity [CNF] latent variable) with EOS and 
SUB items combined under one latent variable; however, this continued to produce a 
non-positive definite covariance matrix. As such, we created a higher-order latent factor 
which allowed for a positive definite matrix in all subsequent models. 
Confirmatory Factor Models with Higher-Order Motivation Factor 
For the 11-factor models (Model 1) we included all 81 MUSQ items examined in 
this study and anchored the two new split indicators (i.e., “To avoid conflict with others” 
and “To manage conflict with others”) within their originally hypothesized latent variable 
(i.e., factor 9; Manage Negative Social Interactions; MNSI). For the ALC group, fit 
statistics demonstrated slightly less-than-acceptable fit (CFI = .889; RMSEA = .071), χ2 
(df = 3148) = 10522.746, p < .001. For the SAM group, fit statistics similarly 
demonstrated less-than-acceptable fit (CFI = .874; RMSEA = .075), χ2 (df = 3148) = 
9845.438, p < .001. 
We examined the hypothesized 10-factor models by testing the fit for MNSI 
indicators on the Positive Social Interactions (factor 5; PSI) latent variable (Model 2). For 
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the ALC group, fit statistics demonstrated slightly less-than-acceptable fit (CFI = .886; 
RMSEA = .072), χ2 (df = 3149) = 10743.713, p < .001. For the SAM group, fit statistics 
similarly demonstrated less-than-acceptable fit (CFI = .872; RMSEA = .076), χ2 (df = 
3149) = 9952.055, p < .001. 
Next, we examined the second hypothesized 10-factor models by testing the fit 
for MNSI indicators on the CNF latent variable (Model 3). For the ALC group, fit 
statistics demonstrated slightly less-than-acceptable fit (CFI = .889; RMSEA = .071), χ2 
(df = 3149) = 10527.942, p < .001. For the SAM group, fit statistics similarly 
demonstrated less-than-acceptable fit (CFI = .874; RMSEA = .076), χ2 (df = 3149) = 
9869.008, p < .001.  
At this point in the analyses, Models 1, 2, and 3 were comparable in fit, with 
Models 2 and 3 being the more parsimonious models across substance groups. To 
determine whether one model would demonstrate better fit compared to the others, we 
examined modification indices across the models. Examination of modification indices 
revealed five items (Item 10 – To reduce feelings of fear; Item 12 – to feel like nothing 
can bother me; Item 36 – To enjoy social interactions; Item 60 – To have fun; and Item 
61 – To celebrate) cross-loaded at a significant magnitude across models and substance 
groups. As such, we excluded these items and examined the models again for SAM and 
ALC users (Models 4, 5, and 6). The 11-factor model (Model 4) revealed increased fit for 
the ALC group (CFI = .922; RMSEA = .063), χ2 (df = 2763) = 7744.272, p < .001, and 
SAM group (CFI = .893; RMSEA = .073), χ2 (df = 2763) = 8311.504, p < .001. The two 
10-factor models (Models 5 and 6) also revealed comparable increased fit for combining 
MNSI and PSI in the ALC group (CFI = .918; RMSEA = .064), χ2 (df = 2764) = 
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7945.623, p < .001, and SAM group (CFI = .891; RMSEA = .074), χ2 (df = 2764) = 
8407.127, p < .001, as well as combining MNSI and CNF in the ALC group (CFI = .915; 
RMSEA = .065), χ2 (df = 2764) = 8160.469, p < .001, and SAM group (CFI = .884; 
RMSEA = .076), χ2 (df = 2764) = 8739.434, p < .001.  
Examination of the modification indices in these models revealed combining 
items from Reduce Anxiety Unpleasant Arousal (Factor 1; RAUA) and Increase Positive 
Affect (Factor 8; IPA) would increase the fit of the models for the SAM group and, to a 
lesser extent, the ALC group. The 10-factor model (i.e., combining RAUA with IPA and 
excluding items 10, 12, 36, 60, and 61; Model 7) revealed slightly increased fit for the 
SAM group (CFI = .898; RMSEA = .071), χ2 (df = 2764) = 8015.440, p < .001, but 
comparable fit compared to the 11-factor model (Model 4) for the ALC group (CFI = 
.922; RMSEA = .062), χ2 (df = 2764) = 7691.276, p < .001. A similar pattern was 
observed in comparing the 9-factor model of combining MNSI with PSI, excluding items 
10, 12, 36, 60, and 61, and combining RAUA with IPA (Model 8) to the same model with 
RAUA and IPA as separate latent factors (Model 5), such that fit improved for the SAM 
group (CFI = .897; RMSEA = .072), χ2 (df = 2765) = 8107.323, p < .001 but remained 
comparable for ALC group (CFI = .919; RMSEA = .063), χ2 (df = 2765) = 7883.210, p < 
.001. Finally, the 9-factor model of combining MNSI with CNF, excluding items 10, 12, 
36, 60, and 61, and combining RAUA with IPA (Model 9) to the same model with 
RAUA and IPAA as separate latent factors (Model 6) revealed slightly increased fit 
across the SAM group (CFI = .898; RMSEA = .071), χ2 (df = 2765) = 8045.108, p < 
.001, and ALC group (CFI = .922; RMSEA = .062), χ2 (df = 2765) = 7705.223, p < .001 
and comparable fit to the 10-factor model combining RAUA with IPA and dropping the 
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five items across groups (Model 7). Therefore, prior to additional post-hoc modifications 
through examination of modification indices, we established Model 9 as the preliminary 
baseline model for both SAM and ALC groups based on (a) the strength of model fit and 
(b) parsimony of latent variables. 
Examination of modification indices for ALC and SAM groups in Model 9 
revealed one item warranted exclusion based on large and double loadings on latent 
variables to improve fit: Item 8 – To relax, loosen up, or unwind. We dropped this item 
from Model 9 (Model 10), which improved fit for the ALC group (CFI = .927; RMSEA = 
.061), χ2 (df = 2691) = 7304.954, p < .001, and SAM group (CFI = .905; RMSEA = 
.070), χ2 (df = 2691) = 7582.684, p < .001, demonstrating acceptable fit across groups.  
Examination of modification indices for ALC and SAM groups in Model 10 
revealed two items warranted exclusion based on large and double loadings on latent 
variables to substantially improve fit for the SAM group and, to a lesser extent, the ALC 
group: Item 68 – To feel more confident or effective and Item 69 – To improve my self-
esteem. We dropped these items from Model 10 (Model 11), which further improved fit 
for the ALC group (CFI = .932; RMSEA = .060), χ2 (df = 2546) = 6750.300, p < .001, 
and SAM group (CFI = .915; RMSEA = .067), χ2 (df = 2546) = 6783.668, p < .001.  
Examination of the modification indices in Model 11 revealed combining items 
from the new latent factor (Factor 1 – combining indicators from RAUA and IPA) with 
Factor 10 (Reduce Negative Affect; RNA) would substantially increase the fit of the 
models for the SAM group and ALC group. This theoretically sound parsimonious 
modification, accounting for motives related to managing emotional states (Model 12), 
revealed increased fit for the ALC group (CFI = .934; RMSEA = .059), χ2 (df = 2547) = 
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6630.123, p < .001, and similar fit for SAM group (CFI = .913; RMSEA = .067), χ2 (df = 
2547) = 6868.491, p < .001, compared to the 9-factor model (Model 11). 
Examination of modification indices for ALC and SAM groups in Model 12 
revealed two items warranted exclusion based on large and double loadings on latent 
variables: Item 3 – To feel less stressed and Item 73 – To feel less ashamed. We dropped 
these items from Model 12 (Model 13), which improved fit for both the ALC group (CFI 
= .938; RMSEA = .058), χ2 (df = 2406) = 6113.691, p < .001, and SAM group (CFI = 
.920; RMSEA = .066), χ2 (df = 2406) = 6267.718, p < .001. 
Examination of modification indices for ALC and SAM groups in Model 13 
revealed one item warranted exclusion based on large and double loadings on latent 
variables: Item 76 – To feel less guilty. We dropped this item from Model 13 (Model 14), 
which improved fit for both the SAM group (CFI = .924; RMSEA = .064), χ2 (df = 2337) 
= 5941.699, p < .001, and demonstrated similar fit for the ALC group (CFI = .938; 
RMSEA = .058), χ2 (df = 2337) = 5951.637, p < .001, compared to Model 13. 
Finally, examination of modification indices for ALC and SAM groups in Model 
14 revealed one item warranted exclusion based on large and double loadings on latent 
variables: Item 38 – To celebrate with others. We dropped this item from Model 14 
(Model 15), which slightly improved fit for both the SAM group (CFI = .926; RMSEA = 
.064), χ2 (df = 2269) = 5768.028, p < .001, and ALC group (CFI = .942; RMSEA = 
.057), χ2 (df = 2269) = 5632.319, p < .001, compared to Model 14. Thus, Model 15 – the 
8-factor model with a higher-order motivation factor; MNSI and CNF items combined 
into one latent factor (broadly managing negative social interactions; MNSI-r); RAUA, 
IPA, and RNA items combined into one latent factor (broadly managing emotional states; 
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MES) and removing Items 3, 8, 10, 12, 36, 60, 61, 68, 69, 73, and 76 – was established as 
the baseline model with acceptable fit based on CFI and RMSEA for the SAM group and 
acceptable and excellent fit based on CFI and RMSEA, respectively, for the ALC group 
(See Table 10 for all alternative baseline model fit statistics). 
Table 10 CFA Baseline Model Fit Statistics for ALC and SAM Users’ MUSQ Responses 
Model 
Fit Indices 
χ2 df p RMSEA CFI 
Model 1 10522.746 3148 <.001 .071 .889 
ALC: 11-factor w/ HO factor 9845.438 3148 <.001 .075 .874 
SAM: 11-factor w/ HO factor      
Model 2      
ALC: 10-factor w/ HO factor 
(MNSI+PSI) 
10743.713 3149 <.001 .072 .886 
SAM: 10-factor w/ HO factor 
(MNSI+PSI) 
9952.055 3149 <.001 .076 .872 
Model 3      
ALC: 10-factor w/ HO factor 
(MNSI+CNF) 
10527.942 3149 <.001 .071 .889 
SAM: 10-factor w/ HO factor 
(MNSI+CNF) 
9869.008 3149 <.001 .076 .874 
Model 4      
ALC: 11-factor w/ HO factor (drop 
Items 10, 12, 36, 60, and 61) 
7744.272 2763 <.001 .063 .922 
SAM: 11-factor w/ HO factor (drop 
Items 10, 12, 36, 60, and 61) 
8311.504 2763 <.001 .073 .893 
Model 5      
ALC: 10-factor w/ HO factor 
(MNSI+PSI; drop Items 10, 12, 36, 60, 
and 61) 
7945.623 2764 <.001 .064 .918 
SAM: 10-factor w/ HO factor 
(MNSI+PSI; drop Items 10, 12, 36, 60, 
and 61) 
8407.127 2764 <.001 .074 .891 
Model 6      
ALC: 10-factor w/ HO factor 
(MNSI+CNF; drop Items 10, 12, 36, 
60, and 61) 
8160.469 2764 <.001 .065 .915 
SAM: 10-factor w/ HO factor 
(MNSI+CNF; drop Items 10, 12, 36, 
60, and 61) 




Table 10 (continued). 
Model 7      
ALC: 10-factor w/ HO factor 
(RAUA+IPA; drop Items 10, 12, 36, 
60, and 61) 
7691.276 2764 <.001 .062 .922 
SAM: 10-factor w/ HO factor 
(RAUA+IPA; drop Items 10, 12, 36, 
60, and 61) 
8015.440 2764 <.001 .071 .898 
Model 8      
ALC: 9-factor w/ HO factor 
(MNSI+PSI and RAUA+IPA; drop 
Items 10, 12, 36, 60, and 61) 
7883.210 2765 <.001 .063 .919 
SAM: 9-factor w/ HO factor 
(MNSI+PSI and RAUA+IPA; drop 
Items 10, 12, 36, 60, and 61) 
8107.323 2765 <.001 .072 .897 
Model 9      
ALC: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 10, 12, 36, 60, and 61) 
7705.223 2765 <.001 .062 .922 
SAM: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 10, 12, 36, 60, and 61) 
8045.108 2765 <.001 .071 .898 
Model 10      
ALC: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 8, 10, 12, 36, 60, and 61) 
7304.954 2691 <.001 .061 .927 
SAM: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 8, 10, 12, 36, 60, and 61) 
7582.684 2691 <.001 .070 .905 
Model 11      
ALC: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 8, 10, 12, 36, 60, 61, 68, and 69) 
6750.300 2546 <.001 .060 .932 
SAM: 9-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA; drop 
Items 8, 10, 12, 36, 60, 61, 68, and 69) 







Table 10 (continued). 
Model 12      
ALC: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 8, 10, 12, 36, 60, 61, 68, and 
69) 
6630.123 2547 <.001 .059 .934 
SAM: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 8, 10, 12, 36, 60, 61, 68, and 
69) 
6868.491 2547 <.001 .067 .913 
Model 13      
ALC: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 60, 61, 68, 
69 and 73) 
6113.691 2406 <.001 .058 .938 
SAM: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 60, 61, 68, 
69 and 73) 
6267.718 2406 <.001 .066 .920 
Model 14      
ALC: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 60, 61, 68, 
69, 73, and 76) 
5951.637 2337 <.001 .058 .938 
SAM: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 60, 61, 68, 
69, 73, and 76) 
5941.699 2337 <.001 .064 .924 
Model 15      
ALC: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 38, 60, 61, 
68, 69, 73, and 76) 
5632.319 2269 <.001 .057 .942 
SAM: 8-factor w/ HO factor 
(MNSI+CNF and RAUA+IPA+RNA; 
drop Items 3, 8, 10, 12, 36, 38, 60, 61, 
68, 69, 73, and 76) 
5768.028 2269 <.001 .064 .926 
 
Hypothesis 3: Internal Consistency of the MUSQ Scales 
Internal consistency reliability was evaluated for the 8-factor baseline model with 
alcohol-only, marijuana-only, and SAM groups, as well as with the total sample. We 
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examined Cronbach’s alpha and the range and mean of corrected item-scale correlations. 
Tables 11-14 include the means, standard deviations, item-scale correlations, mean item-
scale correlations, Cronbach’s alphas, and alphas if deleted for all items and factors for 
the total sample (Table 11) and substance groups (Tables 12-14). 
Cronbach’s alphas ranged from to .847 (SUB) to .956 (MES; total sample), .879 
(RLR) to .957 (MES; alcohol-only), .734 (SUB) to .953 (MES; marijuana-only), and .818 
(APEP) to .947 (MNSI-r; SAM). We conducted alpha-if-item-deleted analyses to 
determine if alphas would greatly improve through deletion of any additional items. Item 
33 (i.e., To make social gatherings and parties more fun) would improve the alpha for PSI 
from .925 by .001 (total sample) and .917 by .002 (alcohol-only). For the alcohol-only 
group, Item 21 (i.e., To enhance the effects of another drug) would improve the alpha for 
EOS from .904 by .001. For the marijuana-only group, two items (Item 72 – To manage 
conflict with others; Item 25 – To help with the side effects of a medication) would 
improve the alpha for MNSI-r from .915 by .004 and EOS from .883 by .008. Deletion of 
any other items would decrease or maintain alphas. Because the alphas for PSI, MNSI-r, 
and EOS were already in the high range, no further items were deleted. All item-scale 
correlations for the factors across all groups were well above the minimum acceptable 
value of .30 or higher. Mean item-scale correlations ranged from .627 (APEP) to .760 
(MNSI-r; total sample), .686 (APEP) to .810 (EOS; alcohol-only), .534 (APEP) to .728 
(MEs; marijuana-only), and .558 (APEP) to .791 (MNSI-r; SAM). 
 
 
Table 11 Means, Standard Deviations, Corrected Item-Total Correlations, and Alphas if Deleted for Total Sample MUSQ  
  
M  SD  
 





1. MES (RAUA/IPA/RNA) – 20 items    .706  .956  
1. To calm down  2.97 1.48  .718  .954 
2. To stop worrying  2.85 1.51  .754  .953 
4. To release tension  3.31 1.51  .722  .954 
5. To feel less on edge  2.96 1.50  .732  .954 
6. To reduce feelings of anxiety or nervousness  3.08 1.57  .714  .954 
7. To slow down racing thoughts  2.53 1.53  .696  .954 
9. To feel less irritable  2.79 1.50  .759  .953 
11. To decrease restlessness  2.53 1.49  .660  .955 
58. To feel more joy or happiness   3.19 1.56  .749  .953 
59. To help me get into a good mood   3.25 1.49  .734  .954 
62. To feel more pleasure  3.21 1.53  .634  .955 
63. To feel more excited  2.86 1.46  .594  .956 
64. To feel content with life  2.76 1.54  .768  .953 
65. To feel alive  2.50 1.53  .659  .955 
66. To feel less bored  2.98 1.51  .627  .955 
67. To feel euphoric or feel at peace  3.18 1.54  .679  .954 
74. To reduce feelings of helplessness  2.36 1.52  .737  .954 
75. To reduce feeling of hopelessness  2.36 1.51  .761  .953 
77. To feel less lonely  2.36 1.45  .699  .954 







Table 11 (continued). 
2. MNSI-r (MNSI+CNF) – 9 items   .760  .936  
13. To not be the only one not doing it  1.78 1.18  .770  .928 
14. To satisfy social pressure to use  1.83 1.27  .794  .927 
15. To be just like everybody else  1.88 1.25  .794  .927 
16. To follow what my friends are doing  1.93 1.21  .724  .931 
17. To avoid being made fun of  1.66 1.14  .801  .927 
18. To avoid being rejected  1.82 1.23  .764  .928 
70. To avoid hurting someone’s feelings  1.73 1.18  .751  .929 
71. To avoid conflict with others  1.86 1.25  .725  .931 
72. To manage conflict with others 1.86 1.22  .713  .931 
3. EOS – 7 items   .759  .922  
19. To counteract the effects of another drug  1.63 1.13  .845  .902 
20. To reduce the effects of, or “come down” off of another drug   1.71 1.16  .773  .909 
21. To enhance the effects of another drug  1.85 1.24  .686  .918 
22. Because I am under the influence of another drug  1.67 1.13  .769  .909 
23. To be able to use another drug for a longer period of time  1.61 1.11  .760  .910 
24. To reduce the effects of another drug   1.60 1.10  .800  .906 
25. To help with the side effects of a medication  1.59 1.12  .677  .918 
4. RLR  – 6 items   .681  .877  
26. Because it has fewer side effects than other drugs  2.30 1.56  .717  .849 
27. Because it is not as bad for you as other drugs  2.37 1.57  .749  .843 
28. Because it does not cause me as many problems as other drugs  2.25 1.56  .747  .844 
29. Because I can handle the high better than with some other drugs  1.98 1.40  .631  .864 
30. To get high / intoxicated with something I think is safer than other 










Table 11 (continued). 
5. PSI – 11 items   .700  .925  
32. To help me feel sociable or friendly   2.81 1.46  .726  .917 
33. To make social gatherings and parties more fun  3.34 1.51  .546  .926 
34. To lose my inhibitions in social situations  2.22 1.34  .634  .921 
35. To feel more confident and sure of myself around others  2.56 1.52  .751  .916 
37. To have a reason/excuse to socialize   2.37 1.36  .690  .919 
39. To feel accepted by others  1.96 1.33  .685  .919 
40. To make friends  2.28 1.36  .746  .916 
41. To help me relate to others better  2.31 1.36  .742  .916 
42. To have a sense of belonging to a social group  2.10 1.31  .713  .918 
43. To communicate with others better  2.35 1.41  .732  .917 
44. To feel more intimate with, connected to, or closer to others  2.49 1.41  .722  .917 
6. REB – 6 items   .734  .902  
45. To break rules  1.70 1.16  .761  .880 
46. To rebel against authority or society  1.70 1.16  .733  .884 
47. To do something risky or dangerous  1.72 1.17  .748  .882 
48. To do something illegal  1.49 1.02  .698  .890 
49. To experience the thrill of doing something I’m not supposed to 













Table 11 (continued). 
7. APEP – 7 items   .627  .858  
51. To change my understanding of my perceptions (e.g., a spiritual 
awakening; special understanding of the universe; realizing the 





52. To experience a blending of senses (e.g., tasting colors; seeing 





53. To alter how I perceive my environment (e.g., hear music in 
greater detail or complexity; enhance or dull sensations; drown out 





54. To cause me to perceive things that are not present (i.e., to 





55. To seek new experiences   2.60 1.46  .575  .846 
56. To help me be more creative  2.36 1.37  .621  .839 
57. To know what it’s like to be under the influence of these 





8. SUB – 3 items    .715  .847  
79. To get the same effects as something I’m prescribed when I run 





80. To get the same amount of the drug I think I need when my doctor 





81. To use a drug that is more powerful than one I have gotten used to  1.63 1.13  .696  .805 
Abbreviations: MES, factor 1, Manage Emotional States; RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; 





Table 12 Means, Standard Deviations, Corrected Item-Total Correlations, and Alphas if Deleted for Alcohol-Only Group 
MUSQ  
  
M  SD  
 





1. MES (RAUA/IPA/RNA) – 20 items    .711  .957  
1. To calm down  2.46 1.31  .717  .955 
2. To stop worrying  2.51 1.40  .764  .954 
4. To release tension  2.88 1.46  .687  .955 
5. To feel less on edge  2.61 1.40  .712  .955 
6. To reduce feelings of anxiety or nervousness  2.67 1.48  .718  .955 
7. To slow down racing thoughts  2.13 1.38  .725  .955 
9. To feel less irritable  2.38 1.38  .756  .954 
11. To decrease restlessness  2.00 1.25  .666  .956 
58. To feel more joy or happiness   2.73 1.44  .724  .955 
59. To help me get into a good mood   2.83 1.43  .694  .955 
62. To feel more pleasure  2.70 1.49  .639  .956 
63. To feel more excited  2.70 1.39  .650  .956 
64. To feel content with life  2.36 1.44  .771  .954 
65. To feel alive  2.25 1.43  .666  .956 
66. To feel less bored  2.52 1.35  .643  .956 
67. To feel euphoric or feel at peace  2.48 1.35  .710  .955 
74. To reduce feelings of helplessness  2.06 1.32  .737  .955 
75. To reduce feeling of hopelessness  1.99 1.31  .745  .955 
77. To feel less lonely  2.12 1.37  .741  .955 






Table 12 (continued). 
2. MNSI-r (MNSI+CNF) – 9 items   .728  .925  
13. To not be the only one not doing it  1.84 1.15  .741  .915 
14. To satisfy social pressure to use  1.89 1.26  .754  .915 
15. To be just like everybody else  1.98 1.23  .742  .915 
16. To follow what my friends are doing  2.01 1.20  .650  .921 
17. To avoid being made fun of  1.71 1.10  .762  .914 
18. To avoid being rejected  1.81 1.19  .720  .917 
70. To avoid hurting someone’s feelings  1.68 1.09  .729  .916 
71. To avoid conflict with others  1.73 1.14  .722  .917 
72. To manage conflict with others 1.72 1.13  .736  .916 
3. EOS – 7 items   .810  .943  
19. To counteract the effects of another drug  1.50 1.07  .893  .926 
20. To reduce the effects of, or “come down” off of another drug   1.49 1.02  .789  .935 
21. To enhance the effects of another drug  1.48 0.98  .799  .935 
22. Because I am under the influence of another drug  1.40 0.87  .789  .936 
23. To be able to use another drug for a longer period of time  1.47 1.02  .784  .936 
24. To reduce the effects of another drug   1.47 1.01  .809  .934 
25. To help with the side effects of a medication  1.44 0.97  .810  .934 
4. RLR  – 6 items   .687  .879  
26. Because it has fewer side effects than other drugs  1.85 1.31  .752  .847 
27. Because it is not as bad for you as other drugs  1.95 1.32  .725  .852 
28. Because it does not cause me as many problems as other drugs  1.83 1.29  .740  .849 
29. Because I can handle the high better than with some other drugs  1.63 1.11  .577  .875 
30. To get high / intoxicated with something I think is safer than other 










Table 12 (continued). 
5. PSI – 11 items   .701  .926  
32. To help me feel sociable or friendly   2.80 1.48  .741  .917 
33. To make social gatherings and parties more fun  3.25 1.52  .553  .927 
34. To lose my inhibitions in social situations  2.10 1.32  .625  .922 
35. To feel more confident and sure of myself around others  2.59 1.52  .756  .916 
37. To have a reason/excuse to socialize   2.38 1.32  .676  .920 
39. To feel accepted by others  2.05 1.33  .671  .920 
40. To make friends  2.36 1.35  .726  .918 
41. To help me relate to others better  2.24 1.29  .724  .918 
42. To have a sense of belonging to a social group  2.20 1.32  .716  .918 
43. To communicate with others better  2.36 1.41  .770  .916 
44. To feel more intimate with, connected to, or closer to others  2.29 1.37  .755  .917 
6. REB – 6 items   .700  .884  
45. To break rules  1.66 1.13  .739  .857 
46. To rebel against authority or society  1.64 1.12  .750  .855 
47. To do something risky or dangerous  1.70 1.17  .721  .859 
48. To do something illegal  1.40 0.92  .603  .878 
49. To experience the thrill of doing something I’m not supposed to 













Table 12 (continued). 
7. APEP – 7 items   .686  .887  
51. To change my understanding of my perceptions (e.g., a spiritual 
awakening; special understanding of the universe; realizing the 





52. To experience a blending of senses (e.g., tasting colors; seeing 





53. To alter how I perceive my environment (e.g., hear music in 
greater detail or complexity; enhance or dull sensations; drown out 





54. To cause me to perceive things that are not present (i.e., to 





55. To seek new experiences   2.35 1.37  .576  .886 
56. To help me be more creative  1.96 1.23  .741  .862 
57. To know what it’s like to be under the influence of these 





8. SUB – 3 items    .768  .880  
79. To get the same effects as something I’m prescribed when I run 





80. To get the same amount of the drug I think I need when my doctor 





81. To use a drug that is more powerful than one I have gotten used to  1.50 1.05  .761  .836 
Abbreviations: MES, factor 1, Manage Emotional States; RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; 





Table 13 Means, Standard Deviations, Corrected Item-Total Correlations, and Alphas if Deleted for Marijuana-Only Group 
MUSQ  
  
M  SD  
 





1. MES (RAUA/IPA/RNA) – 20 items    .728  .953  
1. To calm down  3.57 1.64  .729  .950 
2. To stop worrying  3.22 1.75  .791  .949 
4. To release tension  3.75 1.64  .771  .949 
5. To feel less on edge  3.32 1.73  .799  .949 
6. To reduce feelings of anxiety or nervousness  3.48 1.74  .659  .951 
7. To slow down racing thoughts  2.78 1.74  .727  .950 
9. To feel less irritable  3.22 1.64  .774  .949 
11. To decrease restlessness  3.10 1.71  .627  .951 
58. To feel more joy or happiness   3.51 1.72  .770  .949 
59. To help me get into a good mood   3.54 1.67  .754  .949 
62. To feel more pleasure  3.47 1.67  .565  .952 
63. To feel more excited  2.70 1.61  .484  .953 
64. To feel content with life  3.01 1.63  .737  .950 
65. To feel alive  2.38 1.57  .613  .951 
66. To feel less bored  3.18 1.71  .547  .952 
67. To feel euphoric or feel at peace  3.78 1.60  .605  .951 
74. To reduce feelings of helplessness  2.44 1.72  .744  .950 
75. To reduce feeling of hopelessness  2.48 1.66  .785  .949 
77. To feel less lonely  2.19 1.49  .661  .951 






Table 13 (continued). 
2. MNSI-r (MNSI+CNF) – 9 items   .711  .915  
13. To not be the only one not doing it  1.33 .880  .757  .902 
14. To satisfy social pressure to use  1.38 .880  .768  .901 
15. To be just like everybody else  1.39 .940  .743  .902 
16. To follow what my friends are doing  1.41 .890  .747  .902 
17. To avoid being made fun of  1.27 .870  .804  .899 
18. To avoid being rejected  1.45 .940  .721  .904 
70. To avoid hurting someone’s feelings  1.41 1.02  .684  .906 
71. To avoid conflict with others  1.54 1.03  .633  .910 
72. To manage conflict with others 1.68 1.13  .540  .919 
3. EOS – 7 items   .679  .883  
19. To counteract the effects of another drug  1.40 .850  .725  .860 
20. To reduce the effects of, or “come down” off of another drug   1.53 1.00  .800  .848 
21. To enhance the effects of another drug  1.69 1.08  .586  .878 
22. Because I am under the influence of another drug  1.47 .950  .746  .856 
23. To be able to use another drug for a longer period of time  1.34 .800  .647  .869 
24. To reduce the effects of another drug   1.42 .900  .765  .854 
25. To help with the side effects of a medication  1.52 1.04  .484  .891 
4. RLR  – 6 items   .627  .845  
26. Because it has fewer side effects than other drugs  2.79 1.80  .555  .834 
27. Because it is not as bad for you as other drugs  2.84 1.83  .761  .791 
28. Because it does not cause me as many problems as other drugs  2.49 1.81  .683  .808 
29. Because I can handle the high better than with some other drugs  2.04 1.56  .615  .822 
30. To get high / intoxicated with something I think is safer than other 










Table 13 (continued). 
5. PSI – 11 items   .714  .929  
32. To help me feel sociable or friendly   2.39 1.43  .719  .922 
33. To make social gatherings and parties more fun  3.00 1.60  .590  .929 
34. To lose my inhibitions in social situations  1.96 1.25  .721  .922 
35. To feel more confident and sure of myself around others  2.04 1.43  .764  .920 
37. To have a reason/excuse to socialize   1.98 1.34  .756  .920 
39. To feel accepted by others  1.52 1.08  .643  .925 
40. To make friends  1.77 1.15  .730  .922 
41. To help me relate to others better  2.08 1.38  .800  .918 
42. To have a sense of belonging to a social group  1.63 1.09  .703  .923 
43. To communicate with others better  2.08 1.46  .761  .920 
44. To feel more intimate with, connected to, or closer to others  2.33 1.40  .667  .924 
6. REB – 6 items   .677  .870  
45. To break rules  1.33 .800  .682  .847 
46. To rebel against authority or society  1.49 .940  .636  .855 
47. To do something risky or dangerous  1.36 .910  .670  .848 
48. To do something illegal  1.25 .720  .600  .860 
49. To experience the thrill of doing something I’m not supposed to 













Table 13 (continued). 
7. APEP – 7 items   .534  .800  
51. To change my understanding of my perceptions (e.g., a spiritual 
awakening; special understanding of the universe; realizing the 





52. To experience a blending of senses (e.g., tasting colors; seeing 





53. To alter how I perceive my environment (e.g., hear music in 
greater detail or complexity; enhance or dull sensations; drown out 





54. To cause me to perceive things that are not present (i.e., to 





55. To seek new experiences   2.73 1.58  .603  .760 
56. To help me be more creative  2.63 1.54  .430  .793 
57. To know what it’s like to be under the influence of these 





8. SUB – 3 items    .563  .734  
79. To get the same effects as something I’m prescribed when I run 





80. To get the same amount of the drug I think I need when my doctor 





81. To use a drug that is more powerful than one I have gotten used to  1.34 .850  .543  .668 
Abbreviations: MES, factor 1, Manage Emotional States; RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; 






Table 14 Means, Standard Deviations, Corrected Item-Total Correlations, and Alphas if Deleted for SAM Group MUSQ  
  
M  SD  
 





1. MES (RAUA/IPA/RNA) – 20 items    .661  .945  
1. To calm down  3.29 1.41  .644  .943 
2. To stop worrying  3.07 1.43  .694  .942 
4. To release tension  3.62 1.37  .673  .943 
5. To feel less on edge  3.21 1.42  .677  .942 
6. To reduce feelings of anxiety or nervousness  3.39 1.46  .688  .942 
7. To slow down racing thoughts  2.87 1.49  .587  .944 
9. To feel less irritable  3.08 1.44  .708  .942 
11. To decrease restlessness  2.88 1.45  .588  .944 
58. To feel more joy or happiness   3.58 1.48  .704  .942 
59. To help me get into a good mood   3.60 1.34  .711  .942 
62. To feel more pleasure  3.69 1.31  .560  .944 
63. To feel more excited  3.12 1.43  .611  .944 
64. To feel content with life  3.11 1.50  .743  .941 
65. To feel alive  2.86 1.55  .670  .943 
66. To feel less bored  3.42 1.44  .569  .944 
67. To feel euphoric or feel at peace  3.71 1.39  .577  .944 
74. To reduce feelings of helplessness  2.68 1.58  .720  .942 
75. To reduce feeling of hopelessness  2.74 1.56  .734  .941 
77. To feel less lonely  2.71 1.47  .682  .942 







Table 14 (continued). 
2. MNSI-r (MNSI+CNF) – 9 items   .791  .947  
13. To not be the only one not doing it  1.91 1.30  .786  .941 
14. To satisfy social pressure to use  1.97 1.38  .827  .938 
15. To be just like everybody else  1.97 1.34  .849  .937 
16. To follow what my friends are doing  2.05 1.30  .775  .941 
17. To avoid being made fun of  1.80 1.25  .824  .939 
18. To avoid being rejected  2.01 1.35  .799  .940 
70. To avoid hurting someone’s feelings  1.94 1.31  .774  .941 
71. To avoid conflict with others  2.17 1.41  .741  .943 
72. To manage conflict with others 2.12 1.32  .745  .943 
3. EOS – 7 items   .719  .904  
19. To counteract the effects of another drug  1.89 1.25  .830  .878 
20. To reduce the effects of, or “come down” off of another drug   2.08 1.30  .724  .889 
21. To enhance the effects of another drug  2.38 1.39  .591  .905 
22. Because I am under the influence of another drug  2.09 1.34  .737  .888 
23. To be able to use another drug for a longer period of time  1.90 1.25  .744  .887 
24. To reduce the effects of another drug   1.85 1.24  .792  .882 
25. To help with the side effects of a medication  1.82 1.27  .614  .901 
4. RLR  – 6 items   .668  .869  
26. Because it has fewer side effects than other drugs  2.61 1.58  .729  .836 
27. Because it is not as bad for you as other drugs  2.67 1.60  .724  .837 
28. Because it does not cause me as many problems as other drugs  2.66 1.61  .747  .832 
29. Because I can handle the high better than with some other drugs  2.39 1.52  .634  .853 
30. To get high / intoxicated with something I think is safer than other 










Table 14 (continued). 
5. PSI – 11 items   .677  .917  
32. To help me feel sociable or friendly   3.04 1.41  .688  .909 
33. To make social gatherings and parties more fun  3.61 1.41  .486  .919 
34. To lose my inhibitions in social situations  2.49 1.35  .590  .914 
35. To feel more confident and sure of myself around others  2.76 1.50  .722  .908 
37. To have a reason/excuse to socialize   2.54 1.38  .659  .911 
39. To feel accepted by others  2.05 1.38  .713  .908 
40. To make friends  2.44 1.40  .765  .906 
41. To help me relate to others better  2.49 1.41  .734  .907 
42. To have a sense of belonging to a social group  2.20 1.36  .709  .908 
43. To communicate with others better  2.47 1.38  .668  .910 
44. To feel more intimate with, connected to, or closer to others  2.82 1.41  .714  .908 
6. REB – 6 items   .768  .917  
45. To break rules  1.91 1.29  .781  .900 
46. To rebel against authority or society  1.88 1.27  .731  .907 
47. To do something risky or dangerous  1.92 1.23  .781  .901 
48. To do something illegal  1.72 1.21  .783  .900 
49. To experience the thrill of doing something I’m not supposed to 













Table 14 (continued). 
7. APEP – 7 items   .558  .818  
51. To change my understanding of my perceptions (e.g., a spiritual 
awakening; special understanding of the universe; realizing the 





52. To experience a blending of senses (e.g., tasting colors; seeing 





53. To alter how I perceive my environment (e.g., hear music in 
greater detail or complexity; enhance or dull sensations; drown out 





54. To cause me to perceive things that are not present (i.e., to 





55. To seek new experiences   2.85 1.45  .526  .799 
56. To help me be more creative  2.74 1.33  .508  .801 
57. To know what it’s like to be under the influence of these 





8. SUB – 3 items    .693  .832  
79. To get the same effects as something I’m prescribed when I run 





80. To get the same amount of the drug I think I need when my doctor 





81. To use a drug that is more powerful than one I have gotten used to  1.92 1.28  .660  .802 
Abbreviations: MES, factor 1, Manage Emotional States; RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; 
PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, Altered Perceptions / Experiential Processes; SUB, factor 8, Substitution.  
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Hypothesis 4: Measurement Invariance of the MUSQ Across Substance Groups 
Configural Invariance 
For the multiple group configural model (Model 1), we constrained factor patterns 
(i.e., lower-order and high-order factor patterns) to be equal across groups. The 
configural model demonstrated acceptable fit (CFI = .935; RMSEA = .060), χ2 (df = 
4538) = 11400.060, p < .001, suggesting the factor structure of the MUSQ was invariant 
across alcohol-only and SAM users (Table 15). 
Metric Invariance 
For the multiple group metric models, we constrained lower-order factor loadings 
and higher-order factor loadings to be equal across groups in two separate models. The 
metric higher-order model latent variable covariance matrices were non-positive definite. 
Examination of the output revealed statistically non-significant negative residual factor 
variance for Factor 2 (MNSI-r) in the ALC group and Factor 7 (APEP) in the SAM 
group, suggesting the residual variances for these factors was not statistically different 
than zero. Thus, the metric models were re-examined with the residual variances of 
Factor 2 and Factor 7 fixed to zero.  
For the lower-order metric model (Model 2), the fit was acceptable (CFI = .944; 
RMSEA = .056), χ2 (df = 4601) = 10555.471 p < .001. Compared to Model 1, Model 2 
demonstrated slightly better fit than that of Model 1 (ΔCFI = .009; ΔRMSRA = -.004). 
For the higher-order metric model (Model 3), the fit was acceptable (CFI = .935; RMSEA 
= .060), χ2 (df = 4909) = 11503.223, p < .001. Compared to Model 2, Model 3 
demonstrated slightly worsened fit than Model 2 (ΔCFI = -.009; ΔRMSRA = .004); 
however, this finding did not change the fit to a statistically notable degree and did not 
 
67 
alter the fit compared to the configural model. Therefore, metric invariance for both the 
lower- and higher-order factor models across groups was demonstrated, suggesting the 
latent factor loadings were invariant across alcohol-only and SAM users (Table 15).  
Scalar Invariance 
For the multiple group scalar model (Model 4), we constrained lower- and higher-
order factor loadings, and item thresholds, to be equal across groups. The scalar model 
demonstrated acceptable fit (CFI = .924; RMSEA = .063), χ2 (df = 4954) = 13078.333, p 
< .001; however, Model 4 showed a slight decrease in fit compared to Model 3, as 
evidenced by a decrease in CFI greater than .01 (ΔCFI = -.011; ΔRMSEA = .003). Thus, 
scalar invariance across the groups was not exhibited (Table 15). 
Partial Invariance 
 Due to the lack of scalar invariance, we evaluated the potential for partial 
invariance at the scalar level. Modification indices (MIs) for threshold constraints in 
Model 4 revealed the MIs for the first and second thresholds for Item 21 (i.e., To enhance 
the effects of another drug); first threshold for Item 22 (i.e., Because I am under the 
influence of another drug); first and second thresholds for Item 51(i.e., To change my 
understanding of my perceptions [e.g., a spiritual awakening, special understanding of the 
universe, realizing the meaning in life]); first, second, and third thresholds for Item 53 
(i.e., To alter how I perceive my environment [e.g., hear music in greater detail or 
complexity, enhance or dull sensations, drown out distractions]); and second and third 
thresholds for Item 67 (i.e., To feel euphoric or at peace) were of a notable and 
statistically significant size. Therefore, a partial invariance model (Model 5) was 
examined in which Model 4 was re-run with the constraints for the aforementioned 
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thresholds relaxed. The partial invariance model demonstrated acceptable fit (CFI = .926; 
RMSEA = .062), χ2 (df = 4944) = 12787.105, p < .001 and did not display a notable 
decrease in fit compared to the metric invariance model (Model 3; ΔCFI = -.009; 
ΔRMSEA = .002). As such, partial scalar invariance for the MUSQ was confirmed, with 
all thresholds demonstrating invariance except for two associated with EOS, two 
associated with APEP, and one associated with MES (Table 15). Model 5 indicated that 
thresholds 1 and 2 for Item 21 were .701 and 1.058 for the ALC group and -.319 and .171 
for the SAM group. Threshold 1 for Item 22 was .767 for the ALC group and -.037 for 
the SAM group. Thresholds 1 and 2 for Item 51 were .327 and .877 for the ALC group 
and -.540 and -.075 for the SAM group. Thresholds 1, 2, and 3 for Item 53 were .072, 
.581, and 1.150 for the ALC group and -1.061, -.664, and .065 for the SAM group. 
Finally, thresholds 2 and 3 for Item 67 were .036 and .729 for the ALC group and -.913 
and -.228 for the SAM group. Unstandardized factor loadings for Model 5 are presented 
in Table 16. 
 
 
Table 15 Invariance Fit Statistics for Alcohol-Only and SAM Users’ MUSQ Responses 
Model 
Fit Indices    







Baseline         
ALC 5372.742 2582 <.001 .048 .955    
SAM 5617.937 2582 <.001 .056 .940    
Model 1         
Configural 11400.060 4538 <.001 .060 .935    
Model 2      2 vs 1   
Metric – LO 10555.471 4601 <.001 .056 .944  -.004 .009 
Model 3      3 vs. 2   
Metric – HO 11503.223 4609 <.001 .060 .935  .004 -.009 
Model 4      4 vs 3   
Scalar  13078.333 4954 <.001 .063 .924  .003 -.011 
Model 5      5 vs 3   
Partial 12787.105 4944 <.001 .062 .926  .002 -.009 
Note: χ2, chi-square value; df, degrees of freedom; RMSEA, root mean square error of approximation; CFI, comparative fit index.  









Table 16 Unstandardized Factor Loadings for Model 5 of the MUSQ 





-r EOS RLR PSI REB APEP SUB 
MES            
1. To calm down  1.00         
2. To stop worrying  1.05         
4. To release tension  .967         
5. To feel less on edge  .988         
6. To reduce feelings of anxiety or nervousness  1.03         
7. To slow down racing thoughts  1.04         
9. To feel less irritable  1.11         
11. To decrease restlessness  1.07         
58. To feel more joy or happiness   1.05         
59. To help me get into a good mood   1.03         
62. To feel more pleasure  .955         
63. To feel more excited  1.07         
64. To feel content with life  1.17         
65. To feel alive  1.12         
66. To feel less bored  .976         
67. To feel euphoric or feel at peace  .997         
74. To reduce feelings of helplessness  1.21         
75. To reduce feeling of hopelessness  1.22         
77. To feel less lonely  1.22         
78. To forget, escape, or avoid my memories  1.14         
MNSI-r          
13. To not be the only one not doing it   1.00        
14. To satisfy social pressure to use   1.05        
15. To be just like everybody else   1.04        
16. To follow what my friends are doing   .946        
17. To avoid being made fun of   1.05        
 
 
Table 16 (continued). 
18. To avoid being rejected   1.03        
70. To avoid hurting someone’s feelings   1.02        
71. To avoid conflict with others   .998        
72. To manage conflict with others  1.01        
EOS          
19. To counteract the effects of another drug    1.00       
20. To reduce the effects of, or “come down” off 
of another drug   
  .934       
21. To enhance the effects of another drug    .896       
22. Because I am under the influence of another 
drug  
  .933       
23. To be able to use another drug for a longer 
period of time  
  .981       
24. To reduce the effects of another drug     .987       
25. To help with the side effects of a medication    .967       
RLR          
26. Because it has fewer side effects than other 
drugs  
   1.00      
27. Because it is not as bad for you as other 
drugs  
   .942      
28. Because it does not cause me as many 
problems as other drugs  
   1.02      
29. Because I can handle the high better than with 
some other drugs  
   1.05      
30. To get high / intoxicated with something I 
think is safer than other drugs  
   .953      
31. Because it is more socially acceptable than 
other drugs  
   1.01      
PSI           
32. To help me feel sociable or friendly       1.00     
 
 
Table 16 (continued). 
33. To make social gatherings and parties more 
fun  
    .717     
34. To lose my inhibitions in social situations      1.01     
35. To feel more confident and sure of myself 
around others  
    1.14     
37. To have a reason/excuse to socialize       1.06     
39. To feel accepted by others      1.33     
40. To make friends      1.19     
41. To help me relate to others better      1.20     
42. To have a sense of belonging to a social 
group  
    1.23     
43. To communicate with others better      1.18     
44. To feel more intimate with, connected to, or 
closer to others  
    1.16     
REB           
45. To break rules       1.00    
46. To rebel against authority or society       .925    
47. To do something risky or dangerous       .947    
48. To do something illegal       .906    
49. To experience the thrill of doing something 
I’m not supposed to do  
     .964    
50. To do something socially unacceptable        1.01    
APEP           
51. To change my understanding of my 
perceptions (e.g., a spiritual awakening; special 
understanding of the universe; realizing the 
meaning in life)  
      1.00   
52. To experience a blending of senses (e.g., 
tasting colors; seeing music as colors or patterns)  




Table 16 (continued). 
53. To alter how I perceive my environment (e.g., 
hear music in greater detail or complexity; 
enhance or dull sensations; drown out 
distractions)  
      .863   
54. To cause me to perceive things that are not 
present (i.e., to hallucinate; to see patterns or 
distortions that are not actually present)  
      1.10   
55. To seek new experiences         .893   
56. To help me be more creative        1.01   
57. To know what it’s like to be under the 
influence of these substances  
      1.03   
SUB            
79. To get the same effects as something I’m 
prescribed when I run out of my prescription  
       1.00  
80. To get the same amount of the drug I think I 
need when my doctor won’t prescribe enough to 
me  
       1.04  
81. To use a drug that is more powerful than one 
I have gotten used to  









Table 16 (continued). 
Lower-Order Factors on Higher-Order Factor          
1. MES         1.00 
2. MNSI-r         1.49 
3. EOS         1.50 
4. RLR         1.24 
5. PSI         1.12 
6. REB         1.47 
7. APEP         1.32 
8. SUB         1.52 
Abbreviations: MES, factor 1, Manage Emotional States; RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other Substances; RLR, factor 4, Relative Low Risk; 





Hypothesis 5: Mean Differences in MUSQ Latent Factors 
We attempted to compare group latent factor means by setting the latent factor 
variances to zero for the ALC group and allowing the same latent factors in the SAM 
comparison group to vary; however, the model was not identified at the lower-order level 
because of the newly identified higher-order factor. This was likely due to too many 
parameters being estimated. Additionally, with the higher-order factor in the model 
capturing a large portion of the variance (i.e., residual first-order variances were quite 
small), a comparison of the latent factor scores across groups likely would not be very 
informative. Therefore, we only compared the latent means across groups for the higher-
order factor within the partially invariant scalar model. The higher-order factor mean for 
the SAM group was .530, p < .001, suggesting a .530 standard deviation higher mean in 
the SAM group compared to the ALC group (which was fixed to zero for the purpose of 
testing the group mean difference). 
Given that the latent means comparison model likely would not be meaningful at 
the first-order level within the higher-order model (and also not statistically identified), 
we compared the group means for the observed factor-based subscale scores (defined by 
the mean item response score for each subscale). As such, we conducted eight t-tests with 
a Bonferroni-correction of p < .006 to examine mean differences in the factor-based 
subscale scores across ALC and SAM users. We examined Levene’s Test to determine 
whether the assumption of homogeneity of variance was violated. If significant, we relied 
on the “Equal variances not assumed” output. Results of the t-tests are presented in Table 
17. As can be seen in Table 17, SAM users demonstrated statistically significant higher 
means than ALC users on all MUSQ latent factors except MNSI-r. Specifically, SAM 
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users scored between .21 (PSI) to .77 (APEP) units higher on the majority of MUSQ 
scales than ALC users, suggesting higher frequency of use for most motives. 
Table 17 Multiple Regression Analyses for MUSQ Scale Scores Predicting Use-Related 
Problems 
Factor ALC SAM   
 n M SD n M SD t p 
MES 418 2.43 1.034 354 3.17 1.018 -10.05 <.001* 
MNSI-r 441 1.82 .921 358 1.99 1.114 -2.37 .016 
EOS 440 1.46 .858 361 2.00 1.031 -7.85 <.001* 
RLR 446 1.88 1.023 365 2.59 1.214 -8.99 <.001* 
PSI 436 2.42 1.051 356 2.63 1.036 -2.79 .005* 
REB 447 1.66 0.897 365 1.88 1.072 -3.08 .002* 
APEP 446 1.85 .911 359 2.62 .971 -11.49 <.001* 
SUB 454 1.52 .961 367 1.81 1.062 -4.09 <.001* 
Note: * Significant with Bonferroni correction of p < .006. 
Abbreviations: ALC, alcohol-only users; SAM, simultaneous alcohol and marijuana users; MES, factor 1, Manage Emotional States; 
RAUA, Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, 
Manage Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects 
of Other Substances; RLR, factor 4, Relative Low Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, 
factor 7, Altered Perceptions / Experiential Processes; SUB, factor 8, Substitution. 
Hypothesis 6: MUSQ Motives Predicting Use-Related Problems 
We conducted four multiple regressions with MUSQ scale scores as independent 
variables and corresponding use-related problem variables (i.e., RAPI or MPI) serving as 
the dependent variable. Sample sizes ranged from 144 to 340. Results of these regression 
analyses are presented in Table 18. As seen in Table 18, all models were statistically 
significant and accounted for 30.1 to 52.5 percent of the variance in use-related problems. 
At the individual variable level, Manage Emotional States (MES) was a significant 
positive predicting variable of use-related problems across all models, such that as 
individuals’ frequency of using alcohol, marijuana, or SAM for managing emotional 
states and experiences (e.g., to calm down, to feel more joy or happiness, or to feel less 
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lonely) increased by one unit, use-related problem scores increased by 3.074 (RAPI; 
Model 1); 2.810 (MPI; Model 2); and 2.177 (RAPI; Model 3) and 2.275 (MPI; Model 4), 
respectively. MES was the only significant predictor of use-related problems for SAM 
users (Model 3 and Model 4). 
For Model 1 and Model 2, Effects of Other Substances (EOS) was a significant 
positive predictor of use-related problems for alcohol-only and marijuana-only users. As 
individuals’ frequency of using alcohol-only and marijuana-only for managing the effects 
of other substances (e.g., to counteract or enhance the effects of another substance) 
increased by one unit, use-related problem scores increased by 5.563 (RAPI; Model 1) 
and 5.763 (MPI; Model 2), respectively.   
Contrary to hypotheses, Altered Perceptions/Experiential Processes (APEP) was 
also a significant positive predictor of use-related problems among alcohol-only users 
(Model 1). A one-unit increase in frequency of using alcohol to alter one’s perceptions or 
to seek new experiences (APEP) predicted a 3.713-unit increase in use-related problem 
scores (RAPI). 
Table 18 Multiple Regression Analyses for MUSQ Scale Scores Predicting Use-Related 
Problems 
 
 n R2 B SE B β t p 
Model 1 (ALC - RAPI) 340 .525     <.001* 
     (constant)   -9.373 1.119  -8.379 <.001* 
     MES (Factor 1)   3.074 .686 .293 4.484 <.001* 
     MNSI-r (Factor 2)   1.514 .933 .125 1.624 .105 
     EOS (Factor 3)   5.563 1.376 .411 4.044 <.001* 
     RLR (Factor 4)   -1.223 .668 -.113 -1.83 .068 
     PSI (Factor 5)   -.898 .647 -.088 -1.388 .166 
     REB (Factor 6)   .328 .806 .026 .407 .684 
     APEP (Factor 7)   3.713 .923 .299 4.023 <.001* 
     SUB (Factor 8)   -1.991 1.293 -.157 -1.54 .124 
 
78 
Table 18 (continued). 
Note: * Significant with Bonferroni correction of p < .01. 
Abbreviations: ALC, alcohol-only users; MARIJ, marijuana-only and concurrent users; SAM, simultaneous alcohol and marijuana 
users; RAPI, Rutgers Alcohol Problem Index; MPI, Marijuana Problem Index. MES, factor 1, Manage Emotional States; RAUA, 
Reduce Anxiety / Unpleasant Arousal; IPA, Increase Positive Affect; RNA, Reduce Negative Affect. MNSI-r, factor 2, Manage 
Negative Social Interactions-Revised; MNSI, Manage Negative Social Interactions; CNF, Conformity; EOS, factor 3, Effects of Other 
Substances; RLR, factor 4, Relative Low Risk; PSI, factor 5, Positive Social Interactions; REB, factor 6, Rebellion; APEP, factor 7, 
Altered Perceptions / Experiential Processes; SUB, factor 8, Substitution. 
 
 
Model 2 (MARIJ - MPI) 144 .365     <.001* 
     (constant)   -7.178 2.558  -2.807 .006* 
     MES (Factor 1)   2.810 .792 .308 3.546 .001* 
     MNSI-r (Factor 2)   .575 1.84 .038 .312 .755 
     EOS (Factor 3)   5.763 1.721 .369 3.348 .001* 
     RLR (Factor 4)   .095 .760 .011 .125 .901 
     PSI (Factor 5)   1.514 1.236 .141 1.225 .223 
     REB (Factor 6)   .653 1.928 .039 .338 .736 
     APEP (Factor 7)   -.977 1.035 -.089 -.944 .347 
     SUB (Factor 8)   -1.752 1.911 -.113 -.917 .361 
Model 3 (SAM - RAPI) 290 .350     <.001* 
     (constant)   -3.874 2.108  -1.837 .067 
     MES (Factor 1)   2.177 .856 .177 2.543 .012* 
     MNSI-r (Factor 2)   2.845 1.209 .245 2.354 .019 
     EOS (Factor 3)   .913 1.216 .071 .751 .454 
     RLR (Factor 4)   .089 .658 .009 .135 .893 
     PSI (Factor 5)   .672 1.099 .056 .611 .541 
     REB (Factor 6)   .236 1.013 .019 .233 .816 
     APEP (Factor 7)   -1.416 1.045 -.109 -1.355 .176 
     SUB (Factor 8)   2.685 1.165 .212 2.304 .022 
Model 4 (SAM - MPI) 286 .301     <.001* 
     (constant)   -3.564 2.186  -1.63 .104 
     MES (Factor 1)   2.275 .883 .187 2.577 .010* 
     MNSI-r (Factor 2)   .675 1.236 .059 .546 .586 
     EOS (Factor 3)   2.402 1.258 .190 1.909 .057 
     RLR (Factor 4)   .951 .688 .093 1.382 .168 
     PSI (Factor 5)   .309 1.145 .026 .270 .787 
     REB (Factor 6)   -.228 1.042 -.019 -.218 .827 
     APEP (Factor 7)   -.015 1.075 -.001 -.014 .989 
     SUB (Factor 8)   1.634 1.181 .132 1.383 .168 
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CHAPTER IV – DISCUSSION 
Given the prevalence of alcohol and marijuana use, as well as the compounding 
adverse consequences of use-related problems as a result of simultaneous intoxication, 
the present study sought to further investigate the nature of motives for, and 
consequences of, using these substances. As hypothesized, higher frequency of alcohol-
only, marijuana-only, and simultaneous alcohol and marijuana (SAM) use predicted more 
respective use-related problems. More frequent SAM use predicted greater marijuana 
use-related problems than marijuana-only use; however, increased frequency of alcohol-
only use predicted greater alcohol use-related problems than that for more frequent SAM 
use. This finding runs contrary to previous research that has suggested greater likelihood 
of alcohol-related problems such as alcohol dependence (Midanik, Tam, & Weisner, 
2007) and intoxicated driving (Terry-McElrath, O’Malley, & Johnston, 2013) for SAM 
users compared to alcohol-only users from the 2000 National Alcohol Survey and a 
sample of high school seniors, respectively. Thus, differences here may be attributed to a 
respectively narrower and adult sample. 
To examine the nature of motives for using these substances, the present study 
also sought to investigate the psychometric properties of the Motivations for Using 
Substances Questionnaire (MUSQ) for alcohol, marijuana, and SAM users. Specifically, 
we (a) further evaluated the factor structure of MUSQ scores individually with alcohol 
and SAM users separately, (b) tested the measurement invariance of the MUSQ across 
alcohol and SAM groups, and (c) evaluated multiple indices of internal consistency of the 
MUSQ factor-based subscale scores, including item-total correlations and Cronbach’s 
alpha.   
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CFA Baseline Models 
Prior to invariance testing, individual group CFAs were conducted to establish the 
baseline model with acceptable fit in both groups individually. The previously-
established 12-factor model derived from exploratory factor analysis (EFA) in the MUSQ 
pilot study (Altenberger, 2018) was reduced to three hypothesized models at the outset: 
One 11-factor model that removed the Performance/Arousal Enhancement factor items 
(which are inherently related to stimulant use) and separated a double-barreled Manage 
Negative Social Interactions (MNSI) item to increase the number of items for the factor 
from two to three; and two 10-factor models that allowed the three items from the MNSI 
factor to load with Conformity (CNF) and Positive Social Interactions (PSI) content, 
respectively. Ultimately, an 8-factor model was established as the baseline model due to 
best fit compared to alternative models and through examination of modification indices. 
The baseline model removed 11 items that cross-loaded on multiple latent factors and 
included a higher-order motivation factor; MNSI and CNF items combined into one 
latent factor (broadly managing negative social interactions, as hypothesized; MNSI-r); 
and combined Reduce Anxiety/Unpleasant Arousal (RAUA), Increase Positive Affect 
(IPA), and Reduce Negative Affect (RNA) items into one latent factor (broadly managing 
emotional states; MES). The more parsimonious baseline model demonstrated acceptable 
fit based on CFI and RMSEA for the SAM group and acceptable and excellent fit based 
on CFI and RMSEA, respectively, for the ALC group. Cronbach’s alpha reliabilities for 
the subsequent factor-based subscales for the individual groups and total sample were in 
the good to excellent range and item-scale correlations were well above the minimum 
acceptable value.  
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Measurement Invariance Testing 
Multiple groups CFA was used to test the measurement invariance of the MUSQ 
in a community and university sample of adults who reported past-month use. As 
expected based on prior research (e.g., Meda et al., 2017), the sample distribution was 
predominantly represented by alcohol users (45.6 percent; n = 461), followed by 
simultaneous alcohol and marijuana users (SAM; 37.0 percent; n = 374), which resulted 
in an underpowered sub-sample of marijuana-only users for tests of measurement 
invariance (17.3 percent; n = 175) despite efforts to capture a larger sample by including 
those who use both marijuana and alcohol, but not at the same time, in soliciting 
responses for marijuana-only motives on the MUSQ. As such, invariance testing was 
performed with two groups – alcohol-only (ALC) and SAM users.  
Configural and metric invariance were observed for the MUSQ across ALC and 
SAM groups, suggesting the number of factors and factor loadings were psychometrically 
equivalent for these users. While full scalar invariance was not observed, partial 
invariance at the scalar level demonstrated acceptable fit with the only non-invariant 
parameters being thresholds 1 and 2 for Item 21; threshold 1 for Item 22; thresholds 1 and 
2 for Item 51; thresholds 1, 2, and 3 for Item 53; and thresholds 2 and 3 for Item 67. 
Given that there are five thresholds per item (i.e., 350 total thresholds), non-invariance 
for ten thresholds (2.9 percent) across all items; three thresholds (8.6 percent) for EOS 
items; five thresholds (14 percent) for APEP items; and two thresholds (2.0 percent) for 
MES items can likely be regarded as inconsequential for the measurement of both the 
first-order and second-order factors of the MUSQ. As such, although technically only 
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partial scalar invariance was achieved, scores from the MUSQ can be considered scalar 
invariant across ALC and SAM groups for most practical purposes.  
Inspection of the thresholds that did differ across groups indicated that, for a 
minority of item thresholds, a higher difficulty (or severity) level for the items was 
observed for the ALC group compared to that for the SAM group. Said differently, a 
higher level of the latent factor variable for an ALC user is required to endorse, for 
example, a ‘3” on Item 67 than is required for a SAM user. This difference in thresholds 
for EOS, APEP, and MES items may reflect inherent differences in the psychotropic 
effects of the substances (e.g., the greater likelihood of hallucinating via marijuana versus 
alcohol intoxication) or possibly statistical artifacts due to low endorsement of these 
motives at these frequencies. 
MUSQ Mean Difference Testing across Groups 
Because the MUSQ demonstrated invariance across levels of sequentially greater 
numbers of group invariance constraints, the results suggest the MUSQ is a 
psychometrically appropriate measure to not only assess, but also make meaningful 
comparisons across alcohol and SAM users’ motivations for using these substances. 
Thus, differences in latent factor scores between alcohol and SAM users can be 
understood as legitimate and meaningful, and not due to measurement bias or error. As 
such, we investigated mean differences on motives between alcohol and SAM users. The 
results in our sample indicated that, at both the lower- and higher-order levels and with 
the exception of MNSI-r at the lower-order level, SAM users tended to simultaneously 
use alcohol and marijuana more frequently for all motives compared to how often the 
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ALC group used alcohol by itself for the same reasons. SAM and alcohol-only users did 
not differ in their frequency of use for MNSI-r reasons. 
MUSQ Motives Predicting Use-Related Problems 
Finally, we evaluated the construct validity of the MUSQ by examining the 
MUSQ’s factor scales’ abilities to predict use-related problems. Although the baseline 
model of the MUSQ for this study captured a factor in which content from the three 
broad emotion management factors (RAUA, IPA, and RNA) loaded onto one latent 
variable (i.e., Manage Emotional States; MES), this nevertheless supported our 
hypothesis that these emotion regulation/coping motives would predict greater use-
related problems regardless of which substance group was referenced in MUSQ 
responses. For alcohol- and marijuana-only users, Effects of Other Substances (EOS) was 
also a significant predictor of use-related problems. Compared to a lack of predictive 
power of EOS for SAM users’ use-related problems, this factor may have been more 
salient for problems within the alcohol-only and marijuana-only groups due to the nature 
of the construct. SAM use may inherently occur as a means to manage effects of 
marijuana or alcohol and, therefore, does not contribute to the prediction of problems, 
whereas more frequent alcohol or marijuana use to manage the effects of other substances 
(e.g., cocaine or benzodiazepines) may be associated with more use-related problems. 
Contrary to hypotheses, Altered Perceptions/Experiential Processes (APEP) was also a 
significant positive predictor of use-related problems among alcohol-only users. This 
may be because those pursuing altered perceptions through alcohol use are necessarily 
using greater amounts to achieve this. Manage Negative Social Interactions – Revised 
(MNSI-r; combining Conformity [CNF] and Manage Negative Social Interactions 
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[MNSI] content) and Positive Social Interactions (PSI) did not account for use-related 
problems at the individual variable level. Findings with respect to the relationship 
between social motives and problems have been mixed – more frequent use of alcohol 
and marijuana for conformity and social acceptance motives has been correlated with less 
frequent and lower quantities of consumption for alcohol and marijuana use (e.g., 
Novacek, Raskin, & Hogan, 1991; Grant et al., 2007), whereas more frequent use of 
alcohol and marijuana for positive social motives has predicted higher drinking frequency 
and quantity (Grant et al., 2007) as well as higher frequency of marijuana use-related 
problems (Simons, Correia, Carey, & Borsari, 1998), respectively. Not surprisingly, these 
motives did not appear salient to the prediction of problems in our sample. 
Strengths and Implications of the Current Study 
This study expanded the limited, but growing, current literature on the effects and 
predictors of simultaneous alcohol and marijuana use. To our knowledge, only one study 
has investigated motives for alcohol, marijuana, and SAM use, which was limited to 
conformity, calming/anxiety/arousal reduction (i.e., Calm/Coping), enhancing positive 
effects of other substances (i.e., Positive Effects [similar to the MUSQ’s EOS]), and 
enhancing social experiences SAM motives (i.e., Social [similar to the MUSQ’s PSI]; 
Patrick, Fairlie, & Lee, 2018). The MUSQ allowed for a more comprehensive and 
appropriate assessment of SAM and alcohol motives by directly comparing motives in a 
unity measure as opposed to using separate assessment tools (i.e., the Drinking Motives 
Questionnaire – Revised, Grant, et al., 2007; and a measure developed for the 
aforementioned study). In addition to Patrick and colleague’s four motives, the MUSQ 
captured using to increase positive affect states (e.g., euphoria) and to manage other 
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negative affective states (e.g., loneliness and hopelessness; MES), to substitute one 
substance for another (SUB), because of the relative low risk of using compared to using 
or doing something else (RLR), to rebel (REB), and to manage negative social 
interactions beyond conformity (MNSI-r). For alcohol and SAM users, the MUSQ 
demonstrated acceptable fit and good reliability, as well as aided in the prediction of use-
related problems.  
In addition, this study expanded the generalizability of findings compared to that 
of Patrick and colleague’s research on motives for SAM use. Although most participants 
were considered young adults, our sample ranged from 18 to 71 years of age with an 
average participant age of 25 years. Our sample was also geographically more diverse, 
given that the online data collection allowed for participants across the United States. We 
collected data from both a university and community sample, which aided in the study’s 
external validity. 
The results of this study also reduced the total number of items for the MUSQ 
from 85 derived from the pilot EFA to 70 items that that demonstrated measurement 
invariance across alcohol and SAM users as well as good internal consistency reliability 
and evidence for construct validity. This reduction in items may serve to reduce response 
fatigue and allow for more time-effective assessment in investigating an individual’s 
reasons for use as a target of intervention.  
Limitations and Future Directions 
Despite its strengths, the study was not without limitations. While efforts were 
made to increase the subsample of marijuana-only users, that size of that subsample did 
not yield adequate power to examine the invariance of the MUSQ for this group. More 
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adequate recruitment efforts may need to be made in future studies to capture this 
population, such as promotion of the research at bars, head shops, smoke shops, and 
dispensaries. It may also be beneficial to loosen the eligibility requirements from past-
month use to past 6-month or past-year use; however, concerns regarding retrospective 
memory to reflect on such motives could increase.  
Although our sample was arguably diverse to a degree, there were nevertheless 
limitations to the representativeness of our sample of alcohol, marijuana, and SAM users. 
Approximately 43 percent of the sample were undergraduate students. There were 
disproportionally more women in the alcohol group (69.4 percent) than men and those 
with other gender identities, as well as more men in the SAM group (53.4 percent) than 
women and other gender identities. Our data for use-related problems was also positively 
skewed across substance groups, suggesting a more diverse sample with a broader range 
of problem severity would be beneficial in future studies.  
Participant’s geographical location was not accounted for in this study, which 
may have been an important factor to consider when soliciting reasons for marijuana use, 
as states differ in their legality, cultural acceptability, and medicalization of use. 
Relatedly, numerous functional/self-medication motives (e.g., to sleep, to reduce pain, to 
alleviate medical conditions) were dropped from the initial item content in the MUSQ 
pilot study based upon results of an EFA; however, several participants contacted the 
researcher to note that they felt some of their motives for using marijuana, such as these, 
should have been included. In lieu of removing the Performance/Arousal factor item 
content for marijuana and SAM users’ motive assessment (as irrelevant motives), it may 
be appropriate to re-examine the MUSQ’s factor structure again with the inclusion of 
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functional and self-medication motive items. It may have been the case that there were 
not enough items within this content area to have yielded a reliable factor in the pilot 
study. Thus, it may be useful to write new items within this content area, and conduct a 
psychometric study including the original items that were dropped, combined with the 
new items.  
Finally, for SAM users, we did not include a measure of SAM use-specific 
problems. Participants indicated the degree to which they experienced past-year alcohol-
related and marijuana-related problems with the RAPI and MPI, respectively. Future 
studies may benefit from capturing SAM-specific problems in models of motives 
predicting consequences, such as the degree to which nausea/vomiting, unsafe sex, 
clumsiness in motor functioning, and difficulty concentrating has occurred as a result of 
SAM use. 
Conclusion 
The MUSQ is a psychometrically appropriate assessment tool to evaluate the 
reasons individuals use alcohol by itself and in combination with marijuana. This is the 
first study to directly compare frequency of use for motives in a unitary measure for 
alcohol and SAM users. The performance of the MUSQ should be tested in samples with 
greater variability in use-related problems, as well as with other substance-using groups 
with a particular emphasis in capturing motives for using marijuana by itself. Finally, 
content from the pilot study of the MUSQ related to using for pain and sleep management 
should be included and re-examined with greater attention to data collected from 
individuals in states with and without legal and medicinal privileges for using marijuana 
before completely removing such item content from the measure. It is hoped that 
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continued development and use of the MUSQ will lead to better assessment of motives 
for substance use and, ultimately, for such knowledge to aid in improving the 
effectiveness of both treatment and prevention of substance-related disorders.
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